TW201014862A - Polymerizable chiral compound, polymerizable liquid crystalline composition, liquid crystalline polymer, and optical isomer - Google Patents

Polymerizable chiral compound, polymerizable liquid crystalline composition, liquid crystalline polymer, and optical isomer Download PDF

Info

Publication number
TW201014862A
TW201014862A TW098132460A TW98132460A TW201014862A TW 201014862 A TW201014862 A TW 201014862A TW 098132460 A TW098132460 A TW 098132460A TW 98132460 A TW98132460 A TW 98132460A TW 201014862 A TW201014862 A TW 201014862A
Authority
TW
Taiwan
Prior art keywords
group
compound
polymerizable
independently
liquid crystal
Prior art date
Application number
TW098132460A
Other languages
Chinese (zh)
Other versions
TWI450902B (en
Inventor
Kei Sakamoto
Kentaro Tamura
Original Assignee
Zeon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeon Corp filed Critical Zeon Corp
Publication of TW201014862A publication Critical patent/TW201014862A/en
Application granted granted Critical
Publication of TWI450902B publication Critical patent/TWI450902B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/24Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing nitrogen-to-nitrogen bonds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • C09K19/322Compounds containing a naphthalene ring or a completely or partially hydrogenated naphthalene ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • G02B5/3016Polarising elements involving passive liquid crystal elements
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Polarising Elements (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

Disclosed are: a novel poly merizable chiral compound (a chiralizin~ agents having high helical twisting power;a polymerizable liquid crystalline compo si lion comprising the polymerizable chira: compound and a polymerizable liquid crys talline compound; a liquid crystalline poly mer; and an optical isomer. Specifically disclosed are: a polymerizable chiral corn pound represented by formula (I); a poly merizable liquid crystalline compositior comprising the polymerizable chiral corn pound and a polymerizable liquid crys talline compound; a liquid crystalline poly mer; and an optical isomer. [In the formula Y1 to Y8 indep endently rep re s ent -0 -, - O C(=O~-, -C(=O)-O-~ or the like; G1 and G2 independently represent a divalent aliphati~ group having 1 to 20 carbon atoms, or the like; Z1 and Z2 independently represent al alkenyl group having 2 to 10 carbon atoms or the like; Q1 to Q4 independently repro sent a hydrogen atom, or the like; Al to At independently represent a bivalent aromatic group A having 6 to 30 carbon atoms; X Presents convene selected from the groups consisting of the groups represented by formulae X-i to X-vi Wherein * represents a bond; and L1 to L4 independently represent an alkyl group having 1 to 4 carbon atoms, or the like); and a and b independently represent a number of O or 1.]

Description

201014862 - 四、指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明:無。 五、 本案若有化學式時,請揭示最能顯示發明特徵的化學式: 【化1】 工. ❹ (I) 六、 發明說明: 【發明所屬之技術領域】 本發明有關於具有高螺旋扭轉力的新穎聚合性對掌性 (chiral)化合物、含有該聚合性對掌性化合物的聚合性液 晶組成物、聚合該聚合性液晶組成物而得到液晶性高分子 以及以該液晶性高分子作為構成材料的光學非等向體。 .【先前技術】 具有膽固醇規則性的樹脂層(以下,也可稱為「膽固醇 樹脂層」)具有反射與膽固醇規則性的螺旋旋轉方向一致的 旋轉方向的圓偏光的特性(以下,此特性也稱為「選擇反射 特性」)。 表現此選擇反射特性的波長頻帶是由膽固醇的規則性 的周期決定。藉由使膽固醇規則性的周期分佈寬度變廣, 201014862 可使表現此選擇反射特性的波長頻帶(以下稱「選擇反射 帶」)的寬度變廣。 ’ 若可在可見光的波長範圍形成具有選擇反射頻帶的膽 固醇樹脂層構成的圓偏光分離薄片,則可在入射的自然光 之中,僅反射特定波長的圓偏光,而透過殘餘的圓偏光。 藉由可反射光的反射板等將此反射的光再入射於上述樹脂 層之中彳以進行光的再利用。再者,組合上述圓偏光分 離薄片與1/4波長板,·^高效率地將自然光變換成為直線 偏光。藉由將此直線偏光的方向對準液晶顯示裝置中設置201014862 - IV. Designated representative map: (1) The representative representative of the case is: None. (2) A brief description of the symbol of the representative figure: None. 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: [Chemical 1] Work. ❹ (I) VI. Description of the invention: [Technical field of the invention] The present invention relates to a high helical torsion force A novel polymerizable chiral compound, a polymerizable liquid crystal composition containing the polymerizable palmitic compound, a polymerizable liquid crystal composition obtained by polymerizing the polymerizable liquid crystal composition, and a liquid crystal polymer as a constituent material. Optical anisotropic body. [Prior Art] A resin layer having a regularity of cholesterol (hereinafter also referred to as "cholesterol resin layer") has a characteristic of reflecting circularly polarized light in a rotating direction in accordance with a regular spiral rotation direction of cholesterol (hereinafter, this characteristic is also This is called "selective reflection characteristics"). The wavelength band exhibiting this selective reflection characteristic is determined by the regularity period of cholesterol. By widening the periodic distribution of the regularity of the cholesterol, 201014862 can widen the wavelength band of the selective reflection characteristic (hereinafter referred to as "selective reflection band"). When a circularly polarized light-separating sheet composed of a cholesteric resin layer having a selective reflection band is formed in the wavelength range of visible light, only circularly polarized light of a specific wavelength can be reflected among the incident natural light, and the residual circularly polarized light can be transmitted. This reflected light is incident on the resin layer by a reflection plate or the like which can reflect light to perform light reuse. Further, the circularly polarized light separating sheet and the quarter-wavelength plate are combined to efficiently convert natural light into linear polarized light. By aligning the direction of the linear polarization with the setting in the liquid crystal display device

的聚乙烯醇製等吸收型偏光子的透過方向,可得到高輝度 的液晶顯示裝置D 以往,為了在可見光的波長範圍形成具有選擇反射頻 帶的膽固醇樹脂層,已經研究了各種的對掌性試劑。 例如,特許文獻1之中,已揭示一種(zn_YH_All_〇_c〇_ o-jr-Y12)!·^所示的對掌性化合物,式中,All為交聯基, M11為介晶基、Y11以及Y”為化學結合或_〇_、_s 一c〇_〇_、 -0-C0-、-0-C0_0_、_c〇_N(Ra)_、或—N(Ra) c〇 ,Γ 為 y 價的對掌性基,r為氫原子或n〜C4烷基,卜為2〜6, ZU 為(al)這些基的至少1個為可參與聚加成反應的反應性 基,(a2)這些基的至少2個具有可參與聚加成反應的反應 性基的取代基’(M)限於可滿足條件(al)4(a2),氫原子 或非反應性基。 特許文獻 2 之中,揭示式(Z12-Y13-A12-Y14-M12-Y15)r2xb 所示的聚合性對掌性化合物,A12為間隔,為為的介晶 201014862 基,γ13〜γ15 為化學結合或-0-、、-CO-0-、、 -O-CO-O-、-C〇-N(Rb)-、或-N(Rb)-c〇~ ’ Rb 為氫原子或 n 〜c4 烷基,Xba I·2價的對掌性基,P為2〜6, zl2為(a3)這些基 的至少!個為含有異氰酸醋、異硫氛酸醋、氛酸§旨、環硫 乙烷、氮丙啶、羧基、羥基或胺基;(b2)殘餘的基、氫原 子或非反應性基。 0 特許文獻3之中,揭示式(ΖΗ—γ16一〔 Α13〕ρ_γΐ7—π— Y18-)r4Xc所示的化合物,A13為間隔,Mu為插入c〇_、 -C0-0-、—或-coi而結合,且非取代或具有藉由 ei’㈣基 '甲氧基' 乙氧基、氣、氣、漠' c卜⑽—院 氧羰基或C1~C20-烷基羰基取代的2個伸苯基的介晶基, Y16 〜Y18 為直接結合、-0-、-S-、—C0—〇、、_〇,…、 -CO-NOM-WRo—,zu為能夠聚合的基,㈠為〇卜 〆為2〜6的數值’ X。表示對掌性基,i RC表示cic 或氫。 特許文獻4之中,揭示式m(AU)r5_Y2emxd_ n)r6_w所示的對掌性摻質,式中,取代基以及 變數表示以下的涵義,A14以;5 A15A 1 Λ Α以及Α為1〜30個C原子鏈長的 間隔,Y”23為化學結合、+、〜(务-C(翁^ -〇-〇(=〇)- . -CH=CH-C(=〇)-〇- . -〇^c(=〇)_〇_ , _C(= ,、鲁C( = 〇)…一 -Ο,…CH=N_、-N=ch_ 或~N = N-’ M14為介晶基,pd故条 p 1 〇 日日基R為氫、C1〜C4-烧基,以及zl5 ^氫、Π普烧基、聚合性基或具有聚合性基的基團,以 為選自二無水山梨糖醇、二無水甘露糖醇以及二無水艾度 5 201014862 糖醇(ichtol)構成的族群的二無水己糖醇 此時基η、γ'γ23、 為0或1’ 至少1個的基Π η 4相间或不同皆可, 團。 Aζ纟示聚合性基或含有聚合性基的基 再者’特許文獻5的 仆人铷幺戽主 的在於揭不以下式(1)所示的 質。 趣^生物,以㈣料對掌性摻 【化1】In the transmission direction of an absorption type polarizer such as polyvinyl alcohol, a high-intensity liquid crystal display device D can be obtained. In order to form a cholesterol resin layer having a selective reflection band in the visible light wavelength range, various kinds of palm-shaped reagents have been studied. . For example, in Patent Document 1, a palm compound represented by (zn_YH_All_〇_c〇_o-jr-Y12)!·^ has been disclosed, wherein All is a crosslinking group and M11 is a mesogenic group. , Y11 and Y" are chemical bonds or _〇_, _s_c〇_〇_, -0-C0-, -0-C0_0_, _c〇_N(Ra)_, or -N(Ra) c〇, Γ is a y-valent pair of palmity groups, r is a hydrogen atom or n~C4 alkyl group, and b is 2 to 6, and ZU is (al) at least one of these groups is a reactive group which can participate in a polyaddition reaction. (a2) At least two substituents '(M) having a reactive group which can participate in the polyaddition reaction are limited to satisfy the condition (al) 4 (a2), a hydrogen atom or a non-reactive group. Among them, the polymerizable palmitic compound represented by the formula (Z12-Y13-A12-Y14-M12-Y15)r2xb is disclosed, A12 is a spacer, and is a mesogen 201014862 base, and γ13~γ15 is a chemical bond or -0. -, -CO-0-, -O-CO-O-, -C〇-N(Rb)-, or -N(Rb)-c〇~ ' Rb is a hydrogen atom or an n~c4 alkyl group, Xba I·2 valence of palmarity group, P is 2~6, zl2 is (a3) at least one of these groups contains isocyanate, isothiocyanate, acyl acid § , (cyclohexane), a carboxyl group, a hydroxyl group or an amine group; (b2) a residual group, a hydrogen atom or a non-reactive group. 0 In Patent Document 3, the formula (ΖΗ-γ16_[Α13]ρ_γΐ7 - π - Y18-) r4Xc a compound, A13 is a spacer, Mu is an insertion of c〇_, -C0-0-, - or -coi, and is unsubstituted or has a methoxy group by ei'(tetra) The base of the two phenylene groups substituted by ethoxy, qi, qi, m'c (10) - oxycarbonyl or C1~C20-alkylcarbonyl, Y16 ~ Y18 is direct bond, -0-, -S-, -C0-〇, _〇,..., -CO-NOM-WRo-, zu is a group capable of polymerization, and (a) is a value of 2 to 6 for the ' 〆 。. i RC denotes cic or hydrogen. In Patent Document 4, a palmitic dopant represented by the formula m(AU)r5_Y2emxd_n)r6_w is disclosed, wherein the substituents and variables represent the following meanings, A14 is; 5 A15A 1 Λ Α and Α are intervals of 1 to 30 C atom chain lengths, Y"23 is chemically bonded, +, ~ ((-((〇〇)-. -CH=CH-C( =〇)-〇- . -〇^c(=〇)_〇_ , _C(= , ,Lu C( = 〇)...一-Ο,...CH=N_ -N=ch_ or ~N = N-' M14 is a mesogenic group, pd is a p 1 日 日 日 R R is hydrogen, C1~C4-alkyl, and zl5 ^ hydrogen, decyl, polymerizable Or a group having a polymerizable group, which is a di-anhydrohexitol selected from the group consisting of di-anhydrosorbitol, di-anhydromannitol, and di-anhydrous 5 201014862 sugar alcohol (ichtol) at this time η, γ 'γ23, 0 or 1', at least one of the bases η 4 may be between phases or different. A indicates a polymerizable group or a group containing a polymerizable group. Further, the servant of the patent document 5 is not shown in the following formula (1). Fun ^ creature, with (four) material on the palm of the hand [Chemical 1]

Re-〇~c〇°·-^- 式中,Re以及兔p P1 d 為 F 、 C1 、 Br 、 I 、 CN 、 SCN 、 SF5 、直 鏈狀或分枝狀的碳數片子 屌于30以下,而未取代或以F、Cl、Re-〇~c〇°·-^- where Re and rabbit p P1 d are F, C1, Br, I, CN, SCN, SF5, linear or branched carbon films below 30 Without being replaced or by F, Cl,

Br、I或CN單一或客&此 π _ & 取代,不鄰接1或2以上的(^2基為 --、-S-、-ΝΗ 一、音…c〇_、_c〇〇、__、—_+、 s CO CO s-、-CH=CH-或-CEC” 且以 〇 及/或 s 原子 彼此不直接結合的方式取代的烷基,< Ps-Sp-X' r為Η 或碳原子1〜4的燒某,pc ΑBr, I or CN single or guest & this π _ & substitution, not adjacent to 1 or more (^2 base is ---, -S-, -ΝΗ one, sound ... c〇_, _c〇〇, __, -_+, s CO CO s-, -CH=CH- or -CEC" and an alkyl group substituted with 〇 and/or s atoms not directly bonded to each other, < Ps-Sp-X' r is Η or carbon atom 1~4 burning, pc Α

Ps為此夠聚合的基’ Sp為間隔基或 單結合 ’ r 為 +、m、-CH2〇_、_co—、_coo_、 〇C〇 〇C〇 —〇_、~C0—NRg-、-NRg~C〇-、-〇CH2-、-CH2〇-、 SCH2 CH2S-、-CH=CH-C00-、-00C_CH = CH_或單結合,Rg 為H或碳原子卜4的烷基。 然而,這些文獻記載的〖合物的多數不具有高螺旋扭 201014862 【先前技術文獻】 【特許文獻1】特開平9-20781號公報 【特許文獻2】特開平9_31〇77號公報 【特許文獻3】特開平號公報 【特許文獻4】特開2〇〇〇_3〇9589號公報 【特許文獻5】特開平2〇〇3_137887號公報 【發明内容】 發明欲解決的課題 有鐘於此,本發明的目的在於提供高螺旋扭轉力的新 :聚合性對掌性化合物、含有該聚合性對掌性化合物的聚 :性液晶組成物、聚合該聚合性液晶組成物而得到的液晶 ’局分子以及以該液晶性高分子作為構成材料的光學非等 後、f ^發明者_等以解決上述課題致力研究的結果發現,以 :⑴所示的特定的聚合性對掌性化合物具有高螺旋 轉力(HTP) ’終至完成本發明。 因此’根據本發明的第1, 合性對掌性化合物。第1觀點’提供下述⑴〜⑺的聚 ⑴下式⑴表示的聚合性對掌性化合物: "匕2】 1 GltY2_A1t;Y3-A2^^A3-y4~x_Y QaQ. NN A4\f6 十 A6_YV2-Y8-Z2 (I) 7 201014862 [式中,Y卜Y8各自獨立矣- 廿曰词且表不化學性單結合_〇_、_s_、 _〇_C(=0)- ' ~C(=0)-〇- > Ν ^~C(=0)-0- , -NR1-C(=〇)_ Ν -C(=0)-NR1-—〇-C( = 〇)-NR1-. r( n. n xml -〇( = 0)-〇---NR1-C( = 〇)- 此’ R1表示氫原子或碳數 NR1-、-0-NR1-、或者-NR1-。-,在 卜6的烷基, 以及G2纟自獨立表示可以具有取代基的碳數卜別 的2價脂肪族基,在該脂肪族基中,可以插入_〇_、 -〇-C(=〇)- . -C(=〇)-〇- , -〇-C(=0)_〇_ , -Nr_C(=〇)-. c( 0) NR 、—NR _或者-C(=〇)…但是_〇_以及_s_各自鄰 接2以上而插人的情況除外,在此,r2表示氫原子或碳數 1~6的燒基, Z1以及Z2各自獨立表示可以被鹵素原子取代的碳數 2〜1 0的烯基, Q1 Q4各自獨立表示氫原子、或者可以具有取代基的碳 數1〜6的院基, A1〜A6各自獨立表示碳數6 3〇的2價芳香族a, X表不下述(X-i)〜(X-vi)的任—者的基團, 【化3】 201014862Ps is a polymerizable base 'S is a spacer or a single bond' r is +, m, -CH2〇_, _co-, _coo_, 〇C〇〇C〇-〇_, ~C0-NRg-, -NRg ~C〇-, -〇CH2-, -CH2〇-, SCH2 CH2S-, -CH=CH-C00-, -00C_CH = CH_ or a single bond, Rg is H or an alkyl group of a carbon atom. However, many of the compounds described in these documents do not have a high-spiral twist 201014862. [Prior Art Document] [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei 9-20781 (Patent Document 2) Japanese Patent Publication No. 9-31〇77 Japanese Laid-Open Patent Publication No. JP-A No. Hei. No. Hei. No. Hei. An object of the present invention is to provide a novel polymer twisting force: a polymerizable palmitic compound, a polymerizable liquid crystal composition containing the polymerizable palmitic compound, and a liquid crystal 'incorporated molecule obtained by polymerizing the polymerizable liquid crystal composition; As a result of intensive research to solve the above problems, the liquid crystal polymer as a constituent material, and the like, the specific polymerizability shown in (1) has high helical rotation force to the palm compound. (HTP) 'End to the completion of the present invention. Therefore, according to the first aspect of the present invention, it is a property of a palm compound. The first viewpoint 'provides the following (1) to (7) poly(1) polymerizable palm compound represented by the following formula (1): "匕2] 1 GltY2_A1t; Y3-A2^^A3-y4~x_Y QaQ. NN A4\f6 A6_YV2-Y8-Z2 (I) 7 201014862 [wherein, Y and Y8 are independent of each other - 廿曰 and the table is not chemically combined _〇_, _s_, _〇_C(=0)- ' ~C( =0)-〇- > Ν ^~C(=0)-0- , -NR1-C(=〇)_ Ν -C(=0)-NR1--〇-C( = 〇)-NR1- r( n. n xml -〇( = 0)-〇---NR1-C( = 〇)- This 'R1 represents a hydrogen atom or carbon number NR1-, -0-NR1-, or -NR1-.- The alkyl group of the group 6 and the group of G2 are independently a divalent aliphatic group which may have a carbon number which may have a substituent, and in the aliphatic group, _〇_, -〇-C (=〇 may be inserted. )-. -C(=〇)-〇- , -〇-C(=0)_〇_ , -Nr_C(=〇)-. c( 0) NR , —NR _ or -C(=〇)... However, _〇_ and _s_ are each adjacent to two or more, except for the case where r2 represents a hydrogen atom or a carbon number of 1 to 6, and Z1 and Z2 each independently represent a carbon number which can be substituted by a halogen atom. 2 to 10 0 alkenyl groups, Q1 Q4 each independently represent a hydrogen atom, or may have a substituent A group having a carbon number of 1 to 6 and A1 to A6 each independently represent a divalent aromatic a having a carbon number of 6 3 , and X is not a group of any of (Xi) to (X-vi) described below. 3] 201014862

烷基、碳數卜4的烷氧基、齒素原子、-C00R1、_qc:()r3、 -0C00R1、-C0NHR1、或NHCOR1 ’在此’ R1表示氫原子或碳數 1 ~ 6的烧基, a以及b各自獨立為〇或1)。 (2) 上述式(I)之中,A1〜A6各自獨立表示可以具有取 代基的伸苯基、可以具有取代基的聯伸苯基、或可以具有 取代基的伸萘基之(〗)所述之聚合性對掌性化合物。 (2)上述式(I)之中 X為下述(X-iii) 1 上述式(1)之中,Z1以及Z2各自獨立為CH2=CH-、 CH2=C(CH3)- ^ CH2 = C(C1)- . CH2=Cfl-CH2- ^ CH2=C(CH3)-CH2- ^ 2 CH2=C(CH3)-CH2CH2-、rrn、r> (CH3)2C=CH-CH2-、CH3-CH=CH-、戎 CH3-CH = CH-CH2-。 201014862 【化4】Alkyl group, alkoxy group of carbon number 4, dentate atom, -C00R1, _qc: ()r3, -0C00R1, -C0NHR1, or NHCOR1 'herein' R1 represents a hydrogen atom or a carbon number of 1 to 6 , a and b are each independently 〇 or 1). (2) In the above formula (I), A1 to A6 each independently represent a phenyl group which may have a substituent, a phenyl group which may have a substituent, or a stilbene group which may have a substituent. Said polymerizable to palm compound. (2) In the above formula (I), X is the following (X-iii). 1 In the above formula (1), Z1 and Z2 are each independently CH2=CH-, CH2=C(CH3)-^CH2=C (C1)- . CH2=Cfl-CH2- ^ CH2=C(CH3)-CH2- ^ 2 CH2=C(CH3)-CH2CH2-, rrn, r> (CH3)2C=CH-CH2-, CH3-CH =CH-, 戎CH3-CH = CH-CH2-. 201014862 【化4】

(X-iii) 式中,*表示結合手之(1)~ (3)任一者所述之聚合性對掌性 化合物。 (5)上述式(I)之中,Y卜Y8各自獨立為-C(=0)-0-、 -0-C(=〇)-、或-〇-, G1以及G2各自獨立為可以插入0_、_C(=0)-〇-、 -0-C( = 0)-、-C( = 0)-的-(CH2)6-或-(CH〇4-, Z1以及Z2各自獨立為 CH2=CH-、CH2 = C(CH3)-或 CH2=C(C1)-, A1~A6各自獨立表示下述(A-i)、(A-ii)或(A-iii)所 示的基團, 【化5】 201014862(X-iii) wherein * represents a polymerizable palmitic compound as described in any one of (1) to (3). (5) In the above formula (I), Y and Y8 are each independently -C(=0)-0-, -0-C(=〇)-, or -〇-, and G1 and G2 are each independently insertable. 0_, _C(=0)-〇-, -0-C( = 0)-, -C( = 0)--(CH2)6- or -(CH〇4-, Z1 and Z2 are each independently CH2 =CH-, CH2 = C(CH3)- or CH2=C(C1)-, and A1 to A6 each independently represent a group represented by the following (Ai), (A-ii) or (A-iii), 5] 201014862

(A-i)(A-i)

子、函素原子、可以具有取代基的碳數1〜10的烷基、氰基、a subunit, a functional atom, an alkyl group having 1 to 10 carbon atoms which may have a substituent, a cyano group,

肖基 OR 〇~C(=〇)-R4 - -C(=0)-0R4 ' ~0-C(=0)-0R4 ' NR 以 〇) R、-C( = 〇)-N(R4)R5、或者、-〇-c( = 〇)-n(R4)R5, 在此R、R各自獨立表示氩原子,或可以具有取代 基的碳數卜10的m R4及/或R5為烷基的情況,在該 院基中’可以插入-0-、-S_、_0_c( = 〇)_、—c( = 〇)_〇_、 0 ( 0) 〇 、—NR6 —C( = 0)-、-C(=0)-NR6-、-nr6-、或者 C( 0)仁是,—0-以及-S-各自鄰接2以上而插入的情況 除外在此,R表示氫原子或碳數1〜6的烷基之⑴~(4) 所述之聚合性對掌性化合物, (6)上述式(I)之中,γ卜Υ8各自獨立為_c(=〇)_〇_、 11 201014862肖基OR 〇~C(=〇)-R4 - -C(=0)-0R4 ' ~0-C(=0)-0R4 ' NR 〇) R, -C( = 〇)-N(R4) R5, or -〇-c(= 〇)-n(R4)R5, wherein R and R each independently represent an argon atom, or a carbon number which may have a substituent: m R4 and/or R5 is an alkyl group In the case of the hospital, you can insert -0-, -S_, _0_c( = 〇)_, -c( = 〇)_〇_, 0 (0) 〇, -NR6 -C( = 0)- , -C(=0)-NR6-, -nr6-, or C(0) is the case where -0- and -S- are each adjacent to 2 or more except for the case where R represents a hydrogen atom or a carbon number of 1. ~c(=〇)_〇_, 11 201014862

-0-C(=0)- 〇1以及〇2各自獨立為_((:112)6_或_((:112)4_, Z1以及Z2各自獨立為、CH2=CH_、或CH2=C(CH3), A1〜A6各自獨立表示下述(A_i)所示的基團, 【化6】-0-C(=0)- 〇1 and 〇2 are each independently _((:112)6_ or _((:112)4_, Z1 and Z2 are each independently, CH2=CH_, or CH2=C ( CH3), A1 to A6 each independently represent a group represented by the following (A_i), [Chem. 6]

上述式子中,*表示結合手,Χι〜Χί各自獨立表示氫原 子、齒素原子、可以具有取代基的碳數1〜1()的烷基、氛基、 肖基 、 _〇-C(=〇)-R4 、 _C(=〇)-〇R4 、 -〇_C(=〇)_〇R4 、 NR -c( = 〇)-R4、—c( = 〇)_n(R4)r5、或 _〇_c( = 〇)_n(r4)r5, r4、 R各自獨立表示氫原子,或可以具有取代基的碳數卜丨〇的 烷基,當R4及/或R5為烷基的情況,在該烷基中,可以插 入~〇~、-S-、-0-CO0)-、-C( = 0)-0-、_0_c( = 〇)_〇一、In the above formula, * represents a bonding hand, and Χι~Χί each independently represents a hydrogen atom, a dentate atom, an alkyl group having 1 to 1 (1) carbon atoms which may have a substituent, an aryl group, a Schottky group, and a 〇-C- =〇)-R4, _C(=〇)-〇R4, -〇_C(=〇)_〇R4, NR -c( = 〇)-R4, —c( = 〇)_n(R4)r5, or _〇_c( = 〇)_n(r4)r5, r4, R each independently represent a hydrogen atom, or an alkyl group having a carbon number of a substituent, and when R4 and/or R5 are an alkyl group, In the alkyl group, ~〇~, -S-, -0-CO0)-, -C( = 0)-0-, _0_c( = 〇)_〇一,

NR6'C(=〇)_、-C(=0)_NR6_、_,_、或者 _c(=〇)_,但是, 0〜以及-S-各自鄰接2以上而插入的情況除外,在此,R6 表不氫原子或碳數1〜6的烷基之(1)〜(5)任一者所述之聚 Q性對掌性化合物。 (Ό上述式(I)之中’ γ卜Y8各自獨立為_c( = 〇)_〇一、 〇 C ( =: 〇 ) 一、或—〇 -, G1以及G2各自獨立為—(CH2)6-或_(CH2)4_, Zl以及Z2各自獨立為、CH2 = CH-, 12 201014862NR6'C(=〇)_, -C(=0)_NR6_, _,_, or _c(=〇)_, except that 0~ and -S- are adjacent to each other by 2 or more, except here. R6 represents a poly-Q-to-palm compound as described in any one of (1) to (5) which is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. (ΌIn the above formula (I), 'γ卜 Y8 is independently _c( = 〇)_〇一, 〇C ( =: 〇) one, or —〇-, G1 and G2 are each independently—(CH2) 6- or _(CH2)4_, Zl and Z2 are each independently, CH2 = CH-, 12 201014862

Qi〜Q4各自獨立表示氫原子或甲基, A1~A6各自獨立表示下述(A-i)所示的基團, 化7】Each of Qi to Q4 independently represents a hydrogen atom or a methyl group, and each of A1 to A6 independently represents a group represented by the following (A-i), which is 7]

0 鹵素原子、可以具有取代基的碳數1〜1〇的烷基、氰基、硝 基、OR4、-O-C(=0)-R4 或-C( = 〇)-〇R4, R4 表示氫原子,或可 以具有取代基的碳數1〜10的烧基,當R4為烧基的情況, 在該烧基中’可以插入- 〇-、-S-、-〇-〇(=0)-、= 、 或-C〇0)- ’但是,-〇-以及-S-各自鄰接2以上而插入的情 況除外之(1)〜(6)任一者所述之聚合性對掌性化合物。 根據本發明的第2觀點,提供下述(8)的聚合性液晶組 成物。 (8)含有上述(1)~(7)任一記載的聚合性對掌性化合物 以及聚合性液晶化合物的聚合性液晶組成物。 根據本發明的第3觀點,提供下述(9)的液晶性高分 子0 (9)聚合上述(8)的聚合性液晶組成物而得到的液晶性 高分子。 根據本發明的第4觀點,提供下述(1〇)的光學非等向 體0 13 201014862 (10) X上述(9)記載的液晶性高分子作為構成材料的 光學非等向體。 發明效果 根據本發月,可提供高螺旋扭轉力的新穎聚合性對掌 ί·生化口物3有該聚合性對掌性化合物的聚合性液晶組成 物聚α該聚合性液晶組成物而得到的液晶性高分子以及 以該液晶性高分子作為構成材料的光學非等向體。 【實施方式】 以下,为項詳細地說明本發明的1 )聚合性對掌性化合 物、2 )聚合性液晶組成物、3)液晶性高分子以及4)光學非 等向體。 1)聚合性對掌性化合物 本發明的聚合性對掌性化合物為上述式(1)所示的化 合物。 式(I)之中,Υ卜Υ8各自獨立表示化學性單結合_〇一、 -S-' -〇-C(=〇)-. -C( = 0)-0-' -〇-C( = 〇)-〇-^ -NR]-C(=〇)-, -COOj-NR1-、-0-C( = 0)-NRl—、_NRLC( = 〇)_〇_ 一NRl_c(=〇)_ NR1-、-0-NR1-、或-Nf-O-。 其中,較佳為-0-、-0-C( = 0) -以及 _c(=0)-0-。 R表示氫原子、甲基、乙基、正丙基、異丙基、正丁 基、異丁基、第二丁基、第三丁基、正戊基、異戊基、新 戍基、正己基等碳數卜6的烷基。特別是,R1較佳為氫原 子或甲基。 14 201014862 • G1以及G2各自獨立表示可以具有取代基的碳數卜20 的2價脂肪族基、較佳為可以具有取代基的碳數1〜丨2的2 價脂肪族基。 G1以及G2的碳數1~20的2價脂肪族基可列舉,鏈狀 脂肪族基、具有脂環式構造的碳數1〜2〇的2價脂肪族基 等。其中,由較良好地顯現本發明希望的效果的觀點看來, 較佳為碳數卜20的伸烷基(aikylene)、碳數2〜10的伸烯 基(alkenylene)等鏈狀的脂肪族基,更佳為亞甲基 6 (methylene)、乙烯基(ethylene)、三亞甲基 (trimethylene) ' 丙埽基(pr〇pyiene)、四亞甲基 (tetramethylene)、五亞甲基(pen1:amethylene)、六亞甲 基(hexamethylene)。伸辛基(octamethylene)等碳數卜12 的伸烯基,又更佳為四亞甲基〔_(CH2)4_〕、以及六亞曱基 〔-(CH〇6-〕。 G1以及G2的脂肪族基的取代基例如可列舉氟原子、 氣原子、溴原子、碘原子等的鹵素原子;甲氧基、乙氧基、 正丙氧基、異丙氧基、正丁氧基、第二丁氧基、第三丁氧 基、正戊氧基、正己氧基等碳數的烷氧基等。其中, 以氟原子、甲基氧、乙氧基較佳。 上述脂肪族基之中,可以插入-0-、~s-、u( = 〇)… _C(=0) +、_0_c( = 0)如—nr2_c( = 〇)-、_C ㈣卜叱—、曹— 或_以=0) 一但是_〇_以及_s_各自鄰接2以上而插入的情況 除外。其中較佳為-〇—、_〇_cc( = 〇) 〇以及 -c(=o)-。 15 201014862 在此,R2表示與上述R1相同的氫原子或碳數i~6的烷 基。R以氫原子或甲基較佳。 插入這些基的脂肪族基的具體例可列舉 -ch2-ch2~〇-ch2-ch2- ^ -ch2-ch2-s-ch2-ch2- ^ -ch2-ch2-o- C( = 0)-CH2-CH2-' -CH2-CH2-C( = 0)~〇-ch2-> -CH2-0-C(=0)-0- ch2-ch2-> -CH2-CH2-NR2-C(=0)-CH2-CH2-. -CH2-CH2-C(=0)- NR -CH2-、-CH2-NR2-CH2-CH2-、-CH2-C( = 〇)-CH2-等。 zi以及Z2各自獨立表示可以被由素原子取代的碳數 2〜10的烯基。 g Z1以及Z2之可以被鹵素原子取代的碳數2〜1〇的烯 基,較佳為碳數2~6的烯基。再者,取代基的齒素原子可 列舉氟原子、氣原子、溴原子等,以氣原子較佳。 Z1以及Z2之可以被鹵素原子取代的碳數2〜1〇的烯基 的具體例可列舉 CH2=CH_、CH2=C(CH3)_、CH2=CH CH2_、CH3_ CH=CH-、CH2=CH-CH2-CH2-、CH2=C(CH3)-CH2-CH2-、(CH3)2C = ch-ch2-、(CH3)2C=CH_CH2__CH2_、CH2=c(c1)_、CH2=c(CH3)_ ch2-、ch3-ch=ch-ch2- # 等。 其中,由較良好地顯現本發明本發明希望的效果的觀 點看來,較佳為 CH2 = CH-、CH2 = C(CH3)-、CH2=C(C1 )-、ch2=ch_ CH2-、CH2 = C(CH3)-CH2…或 CH2 = C(CH3)-CH2-CH2-,更佳為 CH2 = CH-、CH2=C(CH3)-、或者 CH2=C(C1)_,又更佳為 CH2 = CH一。0 A halogen atom, an alkyl group having a carbon number of 1 to 1 可以 which may have a substituent, a cyano group, a nitro group, OR4, -OC(=0)-R4 or -C(=〇)-〇R4, and R4 represents a hydrogen atom. Or a carbon group having a carbon number of 1 to 10 which may have a substituent, and when R4 is a burnt group, 'insert-〇-, -S-, -〇-〇(=0)-, =, or -C〇0)- 'But the polymerizable palmitic compound described in any one of (1) to (6) except that -〇- and -S- are adjacent to each other by 2 or more. According to a second aspect of the present invention, there is provided a polymerizable liquid crystal composition of the following (8). (8) A polymerizable liquid crystal composition containing the polymerizable palmitic compound and the polymerizable liquid crystal compound according to any one of the above (1) to (7). According to a third aspect of the present invention, there is provided a liquid crystalline polymer obtained by polymerizing the polymerizable liquid crystal composition of the above (8), wherein the liquid crystalline polymer (9) of the above (9) is polymerized. According to a fourth aspect of the present invention, there is provided an optical anisotropic body of the following (1). The liquid crystal polymer according to the above (9) is an optical anisotropic body as a constituent material. Advantageous Effects of Invention According to the present invention, a novel polymerizable property of a high helical twisting force can be provided, and the polymerizable liquid crystal composition of the palm compound is polymerized with the polymerizable liquid crystal composition of the palmitic compound. A liquid crystalline polymer and an optical anisotropic body using the liquid crystalline polymer as a constituent material. [Embodiment] Hereinafter, 1) a polymerizable palmitic compound, 2) a polymerizable liquid crystal composition, 3) a liquid crystalline polymer, and 4) an optical anisotropic body of the present invention will be described in detail. 1) Polymerizable palmitic compound The polymerizable palmitic compound of the present invention is a compound represented by the above formula (1). In the formula (I), each of the two groups independently represents a chemical single bond _〇一, -S-' -〇-C(=〇)-. -C( = 0)-0-' -〇-C( = 〇)-〇-^ -NR]-C(=〇)-, -COOj-NR1-,-0-C( = 0)-NRl—, _NRLC( = 〇)_〇_ NRl_c(=〇) _ NR1-, -0-NR1-, or -Nf-O-. Among them, preferably -0-, -0-C (= 0) - and _c (=0)-0-. R represents a hydrogen atom, a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a second butyl group, a tert-butyl group, a n-pentyl group, an isopentyl group, a neodecyl group, a hexyl group. An alkyl group having a carbon number of 6 or the like. In particular, R1 is preferably a hydrogen atom or a methyl group. 14 201014862 • G1 and G2 each independently represent a divalent aliphatic group having a carbon number of 20 which may have a substituent, and preferably a divalent aliphatic group having a carbon number of 1 to 2 which may have a substituent. Examples of the divalent aliphatic group having 1 to 20 carbon atoms of G1 and G2 include a chain aliphatic group and a divalent aliphatic group having an alicyclic structure and having 1 to 2 carbon atoms. Among them, a chain aliphatic group such as aikylene having a carbon number of 20 and an alkenylene having a carbon number of 2 to 10 is preferable from the viewpoint of exhibiting a desired effect of the present invention. More preferably, it is methylene, ethylene, trimethylene, pr〇pyiene, tetramethylene, pentamethylene (pen1: Amethylene), hexamethylene. An alkenyl group of carbon number 12 such as octamethylene, more preferably tetramethylene [_(CH2)4_], and hexamethylene [-(CH〇6-]. G1 and G2 Examples of the substituent of the aliphatic group include a halogen atom such as a fluorine atom, a gas atom, a bromine atom or an iodine atom; a methoxy group, an ethoxy group, a n-propoxy group, an isopropoxy group, a n-butoxy group, and a second group; Alkoxy group having a carbon number such as a butoxy group, a third butoxy group, a n-pentyloxy group or a n-hexyloxy group, etc. Among them, a fluorine atom, a methyl oxygen or an ethoxy group is preferred. Among the above aliphatic groups, You can insert -0-, ~s-, u(= 〇)... _C(=0) +, _0_c( = 0) such as -nr2_c( = 〇)-, _C (four) divination, Cao- or _ to =0 ) except that _〇_ and _s_ are inserted adjacent to each other by 2 or more. Among them, -〇-, _〇_cc(= 〇) 〇 and -c(=o)- are preferred. 15 201014862 Here, R2 represents the same hydrogen atom or an alkyl group having a carbon number of i to 6 as the above R1. R is preferably a hydrogen atom or a methyl group. Specific examples of the aliphatic group to which these groups are inserted include -ch2-ch2~〇-ch2-ch2-^-ch2-ch2-s-ch2-ch2-^-ch2-ch2-o-C(=0)-CH2 -CH2-' -CH2-CH2-C( = 0)~〇-ch2-> -CH2-0-C(=0)-0- ch2-ch2-> -CH2-CH2-NR2-C(= 0) -CH2-CH2-. -CH2-CH2-C(=0)-NR-CH2-, -CH2-NR2-CH2-CH2-, -CH2-C(=〇)-CH2- and the like. Each of zi and Z2 independently represents an alkenyl group having 2 to 10 carbon atoms which may be substituted by a perion atom. The alkenyl group having a carbon number of 2 to 1 Å, which may be substituted by a halogen atom, of g Z1 and Z2 is preferably an alkenyl group having 2 to 6 carbon atoms. Further, the dentate atom of the substituent may, for example, be a fluorine atom, a gas atom or a bromine atom, and a gas atom is preferred. Specific examples of the alkenyl group having 2 to 1 carbon atoms of Z1 and Z2 which may be substituted by a halogen atom include CH2=CH_, CH2=C(CH3)_, CH2=CH CH2_, CH3_CH=CH-, CH2=CH. -CH2-CH2-, CH2=C(CH3)-CH2-CH2-, (CH3)2C = ch-ch2-, (CH3)2C=CH_CH2__CH2_, CH2=c(c1)_, CH2=c(CH3)_ Ch2-, ch3-ch=ch-ch2-#, etc. Among them, from the viewpoint of exhibiting the desired effect of the present invention more favorably, CH2 = CH-, CH2 = C(CH3)-, CH2=C(C1)-, ch2=ch_CH2-, CH2 are preferred. = C(CH3)-CH2... or CH2 = C(CH3)-CH2-CH2-, more preferably CH2 = CH-, CH2=C(CH3)-, or CH2=C(C1)_, and more preferably CH2 = CH one.

Qi Q4各自獨立表示氫原子;或者與上述ri相同之可以 具有取代基的碳數的烷基。其中,較佳為各自獨立表 16 201014862 示氫原子或甲基,更佳為各自獨立為氫原子。 A1〜A6各自獨立表示碳數6〜3〇 乙價方香族A。 上述2價的芳香族基可列舉包 #壬p择 言具有1個苯環的單環 方香族碳氫化合物(苯、曱笨、-甲埜 勺么曰士 —甲本等)的2價碳氫基、 具有2個以上、通常為2〜4個苯環的多環芳香族碳氫 化合物(萘、聯苯、三聯苯等)的2價碳氫基。 其中’ A1~A6較佳為,各自獨立* 一 曰锎立表不可以具有取代基 0 的伸苯基;也可以具有取代基的聯伸笨基;或者可以具有 取代基的伸萘基,更佳為下述(A-i)、(A .二 11)或(A-i11)所 示的任一基團’又更佳為(A-i)所示的基團。 【化8】Each of Qi Q4 independently represents a hydrogen atom; or an alkyl group having the same carbon number as the above ri which may have a substituent. Among them, it is preferred that each of the independent tables 16 201014862 represents a hydrogen atom or a methyl group, and more preferably each independently represents a hydrogen atom. A1 to A6 each independently represent a carbon number of 6 to 3 〇. The above-mentioned divalent aromatic group may be exemplified by a package of #壬p, a monocyclic aromatic hydrocarbon having one benzene ring (benzene, sputum, scorpion, scorpion, etc.) a divalent hydrocarbon group having a hydrocarbon group and a polycyclic aromatic hydrocarbon (naphthalene, biphenyl, terphenyl, etc.) having two or more, usually 2 to 4, benzene rings. Wherein 'A1 to A6 are preferably each independently * a phenyl group which may not have a substituent 0; a coupling group which may have a substituent; or a naphthyl group which may have a substituent, It is preferably a group represented by the following (Ai), (A. 2-11) or (A-i11) and more preferably a group represented by (Ai). 【化8】

(A-i) (A-ii) 上述式子中,*表示結合手’ Xl〜Xl8各自獨立表示氣原 17 201014862 子、ii素原子、可以具有取代基的碳數w〇的烧基、氣基、 硝基、OR4 、 -0—c(=0)_r4 、 _C(=0)_0R4 、 _〇c(=〇)_〇r4 、 -nr5-c(=o)~R4、_c(=〇) n(r4)r5、或者、_〇_c(=〇)—n(r4)r5。 在此,R、r5各自獨立表示氫原子;或可以具有取代 基的碳數1〜1〇的烷基。 R R之可以具有取代基的碳數1~1〇的院基可列舉甲 基、乙基、正丙基、異丙基、正丁基、第二丁基異丁基、 第三丁基、正戊基、正己基、正庚基、正辛基正壬基、 癸基等較佳為曱基、乙基、正丙基以及異丙基。 上述可以具有取代基的碳數卜1〇的烷基的取代基3 列舉氟原子、氣原子、漠原子、碘原子等的㈣原子;” 氧基〔氧基 '正丙氧基、異丙氧基、正丁氧基、第二] 氧基、第二丁氧基、正戊氧基、正己氧基等魏卜6的另 氧基等。 再者,當 可以插入、 -NR6-C(=〇)-、 R4及/或R5為烷基的情況,在該烷基中,也 -S 〇-C( = 0)---C( = 〇)-〇---0—c( = 〇)-〇-、 ~C( = 0)-NR6-、-NR6- nC(=〇)_。 但疋以及-S-各自鄰接2以上而插入的情況除外。 在此’ K6表示氳原子或與上述R1相同的碳數卜6的烷 Λ衣不上述(X- (li)〜(X-iii) ’ 更佳為(x_iU, 式(x-i)〜α-vi)中,*表示結合手。 各自獨立表不甲基、乙基等的碳數1〜4的爲 18 201014862 曱氧基、乙氧基等的碳數卜4的烷氧基;氟原子、氣原子、 漠原子等的函素原子;-C00R3 ; -〇c〇R3 ; -0C00R3 ; -C0NHR3 ; 或 NHC0R3。 在此,R3表示氫原子或與上述R1相同的碳數卜6的烷 基0 a以及b各自獨立表示〇或i’由合成容易度的觀點看 來’a以及b兩者較佳為同時為〇或1,再者由螺旋扭轉力 的觀點看來,3以及b兩者更佳為同時為j。 本發明的聚合性對掌性化合物較佳為下述U),更佳 為(冷),又更佳為(γ)。 (α)上述式(I)中,ν Y1 Υ8各自獨立為_c( = 〇)_〇一、 _〇-C(=〇)-、或-〇_ , G1以及G2各自獨立為也可以 -〇-C(C=0)- > 1 ϋ)~0' ' ~的—(CH2)6-或- (CH2)4-,Ζ1 以及 Ζ2 夂 自獨立為CH2 = CH~、Γϊΐ〜 及Ζ2各 獨立為上川 (CH3)_或CH,-,A1〜A6各自 獨立為上达(Ay)、(A . _ 目 物。 )或(A_:U1)所示任一基團的化合 以)上述式(1) -0-C( = 0)_、或_〇〜,各自獨立為-c(=〇)_〇_ G1以及G2各自想六从 各自獨立為CH2=CH_hK㈤「或,.’21以及22 )所示的基團的化:\CH2=WH3)” A1~A6各自獨立為 (了)上述式(T、tb -〇-c(=〇)—、或_〇〜,,n〜Y8 各自獨立為-c(=〇)-0_、 19 201014862 G1以及G2各自獨立為-(CH2)6_或_(CH2)4_,ζι以及μ 各自獨立為CHfCH-,Ql以及Q2各自獨立為氫原子或甲基 A1 A6各自獨立為(A_j)所示的基團的化合物。 (2)聚合性對掌性化合物的製造 本發明的聚合性對掌性化合物可將形成、—弘 -NH-C(=0)- > -C( = 〇)-NH- , -NH-C( = 0)-NH- ^ -〇-〇( = 〇)_ ,(Ai) (A-ii) In the above formula, * indicates that the bonding hands 'X1 to Xl8' each independently represent a gas atom, a ii atom, a carbon number which may have a substituent, and a gas group, Nitro, OR4, -0-c(=0)_r4, _C(=0)_0R4, _〇c(=〇)_〇r4, -nr5-c(=o)~R4, _c(=〇) n (r4) r5, or _〇_c(=〇)-n(r4)r5. Here, R and r5 each independently represent a hydrogen atom; or an alkyl group having 1 to 1 Å carbon atoms which may have a substituent. Examples of the substituent group having a carbon number of 1 to 1 RR having a substituent include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, a second butyl isobutyl group, a third butyl group, and a positive group. The pentyl group, the n-hexyl group, the n-heptyl group, the n-octyl-n-decyl group, the fluorenyl group and the like are preferably an anthracenyl group, an ethyl group, a n-propyl group and an isopropyl group. The substituent 3 of the above-mentioned alkyl group having a carbon number which may have a substituent includes a (iv) atom such as a fluorine atom, a gas atom, a desert atom or an iodine atom; "oxy"oxy-n-propoxy group, isopropoxy a further oxy group such as a butyl group, a n-butoxy group, a second oxy group, a second butyloxy group, a n-pentyloxy group or a n-hexyloxy group, etc. Further, when it can be inserted, -NR6-C (= 〇)-, R4 and/or R5 is an alkyl group, and in the alkyl group, -S 〇-C( = 0)---C( = 〇)-〇---0-c( = 〇 ) -〇-, ~C( = 0)-NR6-, -NR6- nC(=〇)_. Except that 疋 and -S- are adjacent to each other by 2 or more. In this case, 'K6 means 氲 atom or The above-mentioned carbon number of the same R1 is not the above (X-(li)~(X-iii)' is more preferably (x_iU, formula (xi)~α-vi), and * means a bonding hand. The carbon number of 1 to 4, such as a methyl group or an ethyl group, is an alkoxy group having a carbon number of 4 such as a hydroxyl group or an ethoxy group; and a hydroxyl atom such as a fluorine atom, a gas atom or a desert atom; ;-C00R3 ; -〇c〇R3 ; -0C00R3 ; -C0NHR3 ; or NHC0R3. Here, R3 represents a hydrogen atom or the same as above R1. The alkyl groups 0 a and b of the number 6 independently represent 〇 or i'. From the viewpoint of ease of synthesis, both 'a and b are preferably simultaneously 〇 or 1, and from the viewpoint of the helical torsion force Preferably, both of 3 and b are simultaneously j. The polymerizable palmitic compound of the present invention is preferably the following U), more preferably (cold), more preferably (γ). (α) In (I), ν Y1 Υ8 are each independently _c( = 〇)_〇一, _〇-C(=〇)-, or -〇_, G1 and G2 are each independently - 〇-C(C =0)- > 1 ϋ)~0' '~—(CH2)6- or -(CH2)4-, Ζ1 and Ζ2 夂Separately CH2 = CH~, Γϊΐ~ and Ζ2 are independent of Shangchuan ( CH3)_ or CH,-,A1~A6 are each independently a combination of any of the groups represented by (Ay), (A. _ object.) or (A_:U1) to the above formula (1) - 0-C(= 0)_, or _〇~, each independently -c(=〇)_〇_ G1 and G2 each want to be six independent from each other as CH2=CH_hK(5) "or,.'21 and 22) The grouping of the group: \CH2=WH3)" A1~A6 are each independently (T, tb -〇-c(=〇)-, or _〇~,, n~Y8 are independent -c(=〇)-0_, 19 201014862 G1 and G2 are each independently -(CH2)6_ or _(CH2)4_, ζι and μ are each independently CHfCH-, and Ql and Q2 are each independently a hydrogen atom or a methyl group. A1 A6 is each independently a compound of the group represented by (A_j). (2) Polymerization of the palm compound The polymerizable palmitic compound of the present invention can be formed, -Hong-NH-C(=0)->-C(=〇)-NH-, -NH- C( = 0)-NH- ^ -〇-〇( = 〇)_ ,

-C〇0)-0-等任一者的各種化學結合的習知的方法(例如, Sandler . karo官能基別有機化合物合成法[〗]、[丨I]廣川 書店、1976年發行參照)組合而製造。 本發明的聚合性對掌性化合物,典型地可藉由任意組 合醚結合(-0-)、酯結合(_c( = 〇)_〇—)、醯胺結合"㈣二 以及氣酸(-C0C1)的形成反應,而適當結合.改質具有希望 的構造的複數個習知的化合物以製造。 醚結合的形成例如可如下述方式進行。a conventional method of chemical combination of any of -C〇0)-0- (for example, Sandler. karo functional organic compound synthesis method [〗], [丨I] Hirokawa Bookstore, 1976 issue reference) Made by combination. The polymerizable palmitic compound of the present invention can be typically combined by any combination of ether (-0-), ester binding (_c(= 〇)_〇-), guanamine combination "(four) two, and qi acid (- The formation reaction of C0C1), with appropriate combination, is modified to produce a plurality of conventional compounds having a desired structure. The formation of the ether bond can be carried out, for example, in the following manner.

⑴使式:D卜ha1(hal表示齒素原子)所示的化合物虚 式:D2-〇Met-(Met表示驗金屬,(主要為鈉),以下相同 所示的化合物混合而縮合。並且,式中,Di卩及Μ表示 任意的有機基Β(以下相同)。此反應通常稱為威廉森 (Wi 11 iamson)合成。 ⑴)在氫氧化納、氫氧化料的鹽基的存在下,使式. D1—㈤所示的化合物與式所示的化合物混合而縮 合〇 (111)在氫氧化納、氫氧化舞等的鹽基的存在下,使 式卜E(E表示環氧基)所示的化合物與式:D2_QH所示的 20 201014862 - 化合物混合而縮合。 (iv) 在氫氧化鈉、氫氧化鈣等的鹽基的存在下,使式: D1-0FN(0FN表示具有不飽和結合的基團)所示的化合物與 式:D2-OMet所示的化合物混合而進行加成反應。 (v) 在銅或者氣化亞銅的存在下,使式:Dl-hal所示 的化合物與式:D2-0Met所示的化合物混合而縮合。此反 應通常稱為烏爾曼(U1 lmann)縮合。 酯結合以及醯胺結合的形成例如可如以下方式進行。 β (vi)在脫水縮合劑(Ν-Ν,二環己基碳二亞胺)的存在 下使式:D1-C00H示的化合物與D2-0H或D2-NH2所示的化 合物脫水縮合。 (vii) 藉由使鹵化劑作用於式:d卜C00H所示的化合 物’得到D卜C0-hal所示的化合物,在鹽基的存在下使此 化合物與式:D2-0H或D2-NH2所示的化合物反應。 (viii) 藉由將酸無水物作用於式:di_c〇OH所示的化 ^ 合物,得到混合酸無水物後,使式:D2-0H或D2_NH2所示 的化合物在此化合物中反應。 (ix) 在酸觸媒或者鹽基觸媒的存在下,使式:-C00H 所示的化合物與式:D2-0H或D2_NH2所示的化合物脫水縮 合0 氯酸的形成,例如可利用以下所述的方式進行。 (X)使三氣化磷或五氣化磷作用於式:Dl_c〇〇H所示的 化合物。 (xi)使氣化亞碾作用於式:IU-C00H所示的化合物。 21 201014862 (xii) 使草醯氣作用於式:M_C〇〇H所示的化合物。 (xiii) 使氣作用於式:Dl-C00Ag(Ag:銀元素)所示的 化合物。 (xiv)使紅色氧化汞的四氣化碳溶液作用於式: D1 -C00H所示的化合物。 再者,本發明的聚合性對掌性化合物(特別是,具有非 對稱構造的聚合性對掌性化合物的製造時)過程中,也有可 藉由保護存在於中間體的氫氧基使合成容易,且提高產率 的情況。 保護氫氧基的方法,可利用習知的方法(例如參照(1) A compound represented by the formula: D: ha1 (hal represents a dentate atom): D2-〇Met- (Met represents a metal test, (mainly sodium), and the same compounds shown below are mixed and condensed. In the formula, Di卩 and Μ represent an arbitrary organic hydrazine (the same applies hereinafter.) This reaction is generally called Wi 11 iamson synthesis. (1)) In the presence of a sodium hydroxide or a hydroxide base, The compound represented by the formula D1-(5) is mixed with the compound represented by the formula to condense oxime (111) in the presence of a salt group such as sodium hydroxide or hydrogen hydroxide, and the formula E (E represents an epoxy group) The compound shown is condensed by mixing with the compound of formula: D2_QH, 20 201014862 - compound. (iv) a compound represented by the formula: D1-0FN (0FN represents a group having an unsaturated bond) and a compound represented by the formula: D2-OMet in the presence of a salt group such as sodium hydroxide or calcium hydroxide The addition reaction is carried out by mixing. (v) A compound represented by the formula: Dl-hal is condensed by mixing with a compound represented by the formula: D2-0Met in the presence of copper or vaporized cuprous. This reaction is commonly referred to as the U1 lmann condensation. The formation of ester bonding and guanamine binding can be carried out, for example, in the following manner. β (vi) Dehydration condensation of a compound of the formula: D1-C00H with a compound of D2-0H or D2-NH2 in the presence of a dehydrating condensing agent (Ν-Ν, dicyclohexylcarbodiimide). (vii) obtaining a compound represented by D-C0-hal by causing a halogenating agent to act on a compound of the formula: d: C00H, and bringing the compound to the formula: D2-0H or D2-NH2 in the presence of a salt group The compound shown is reacted. (viii) A compound represented by the formula: D2-0H or D2_NH2 is reacted in the compound by reacting an acid anhydride with a compound represented by the formula: di_c〇OH to obtain a mixed acid anhydride. (ix) Dehydration condensation of a compound represented by the formula: -C00H with a compound represented by the formula: D2-0H or D2_NH2 in the presence of an acid catalyst or a salt-based catalyst, for example, the following may be used. The manner described is carried out. (X) A compound of the formula: Dl_c〇〇H is allowed to act on phosphorus trioxide or phosphorus pentaoxide. (xi) The gasification sub-grinding is applied to a compound of the formula: IU-C00H. 21 201014862 (xii) The herbaceous gas is applied to the compound of the formula: M_C〇〇H. (xiii) The gas is allowed to act on a compound represented by the formula: Dl-C00Ag (Ag: silver element). (xiv) A solution of red oxidized mercury in a carbonized carbon solution is applied to a compound of the formula: D1 - C00H. Further, in the process of the polymerizable palmitic compound of the present invention (particularly, in the case of producing a polymerizable palmitic compound having an asymmetric structure), it is also possible to facilitate the synthesis by protecting the hydroxyl group present in the intermediate. And increase the yield. A method of protecting a hydroxyl group can be carried out by a conventional method (for example, reference

Greene s Protective Groups in Organic Synthesis 第 3版出版:Wiley-Interscience、1999年發行)而製造。 氫氧基的保護,例如可利用下述的方式進行。 (xv)在咪唑、„比啶等的鹽基的存在下使式·· D1D2D3-Si-hal所示的化合物與式D4: _〇H所示的化合物 混合而反m m中’ D3、D4表示任意的有機基b(以 下相同)。 (XV1)在對甲苯磺酸、吡啶對甲苯磺酸鹽、氣化氫等的 酸的存在下使3,4-一氫-211-"比喃等的乙締基喊與|)2_〇11 所示的化合物混合而反應。 (xvh)在三乙基胺、吡啶等的鹽基的存在下,使式: D1_C(=0)-hal所示的化合物與式:",所示的化合物混 合而反應。 ㈤⑴使式:= —D2所㈣酸無水物 201014862 • 與式:D3-〇H所示的化合物混合而反應,或者在氫氧化鈉、 三乙基胺等的鹽基的存在下混合而反應。 (xix)在氫氧化鈉、三乙基胺等的鹽基的存在下,使 式:Dl-hal所示的化合物與⑽-卯所示的化合物混合而反 應。 (XX)在氫化鈉、氫氧化鈉、三乙基胺、吡啶等的鹽基 的存在下使式:m-ο-CH2-hal所示的化合物與D2 〇H所示 的化合物混合而反應。 ® (xxi)在碳酸鈣、氫氧化鈉等的鹽基的存在下使式:Greene s Protective Groups in Organic Synthesis, 3rd edition, published by Wiley-Interscience, issued in 1999. The protection of the hydroxyl group can be carried out, for example, in the following manner. (xv) a compound represented by the formula D1D2D3-Si-hal is mixed with a compound represented by the formula D4: _〇H in the presence of a salt group such as imidazole or pyridine, and is represented by 'D3, D4' in the opposite mm. Any organic group b (the same applies hereinafter). (XV1) In the presence of an acid such as p-toluenesulfonic acid, pyridine p-toluenesulfonate or hydrogenated hydrogen, 3,4-hydrogen-211-" The ethyl group is shouted and reacted with a compound represented by |) 2_〇11. (xvh) In the presence of a salt group such as triethylamine or pyridine, the formula: D1_C(=0)-hal is shown. The compound is reacted with a compound of the formula: ", and is mixed. (5) (1) Let formula: = - D2 (tetra) acid anhydrate 201014862 • Mix with a compound of the formula: D3-〇H, or react with sodium hydroxide And reacting in the presence of a salt group such as triethylamine, etc. (xix) a compound represented by the formula: Dl-hal and (10)-卯 in the presence of a salt group such as sodium hydroxide or triethylamine The compound shown is mixed and reacted. (XX) A compound represented by the formula: m-o-CH2-hal is reacted with D2 〇H in the presence of a salt group of sodium hydride, sodium hydroxide, triethylamine, pyridine or the like. Shown Mixing the reaction of a compound ® (xxi) salt of formula in the presence of calcium carbonate, such as sodium hydroxide:

Dl-0-CH2(=0)-hal所示的化合物與D2_〇Hm示的化合物混 合而反應。 (XX 11)在二乙基胺、吡啶等的鹽基的存在下使式: di-o-cim=o)-hai所示的化合物與D2_〇H*示的化合物混 合而反應。 脫保護可根據保護基的構造、種類,利用習知的方法 ^ 進行脫保護。 (xxiii)混合四丁基氟化銨等氟離子以脫保護。 (XXIV) 在對甲苯磺酸、《»比啶對曱笨磺酸鹽、氣化氫、 醋酸等的酸的存在下混合而脫保護。 (XXV) 在氫化鈉、氫氧化鈉、氫氧化鈣、碳酸鈉、碳酸 鈣-乙基胺、11比咬等鹽基的存在下混合而脫保護。 (xxvi)在Pd-C等觸媒的存在下,藉由添加氫而脫保 護。 本發明的聚合性對掌性化合物,例如具體地可以下列 23 201014862 方式得到 【化9】 Q2—C—A3—Y4—X—Y5-A4—C—〇3 Ο ⑵ ΟThe compound represented by Dl-0-CH2(=0)-hal is reacted with a compound represented by D2_〇Hm to react. (XX 11) A compound represented by the formula: di-o-cim=o)-hai is mixed with a compound represented by D2_〇H* in the presence of a salt group such as diethylamine or pyridine. Deprotection can be carried out by a conventional method according to the structure and type of the protecting group. (xxiii) Mixing fluoride ions such as tetrabutylammonium fluoride to deprotect. (XXIV) Deprotection by mixing in the presence of p-toluenesulfonic acid, "bispyridinium sulfonate, hydrogenated hydrogen, acetic acid, etc.". (XXV) Deprotection by mixing in the presence of a sodium salt such as sodium hydride, sodium hydroxide, calcium hydroxide, sodium carbonate, calcium carbonate-ethylamine or 11 bite. (xxvi) Deprotection by the addition of hydrogen in the presence of a catalyst such as Pd-C. The polymerizable palmitic compound of the present invention, for example, can be specifically obtained by the following method: [2010] Q2—C—A3—Y4—X—Y5-A4—C—〇3 Ο (2) Ο

Tl·/ 1)NH2NH2 2)Tl-A2-C(=〇XJ! +T2-A5-C(=0)Q4Tl·/ 1)NH2NH2 2)Tl-A2-C(=〇XJ! +T2-A5-C(=0)Q4

Pi 〇2 A3—Y4-Pi 〇2 A3—Y4-

N—N x—Y5—A4—^A5-T2 N—N (3) Y3—A1-Y2^G1-Y 卜Z1 (4a) + Y6'-(—A6—Y7)jG2—-Y8—Z2 (4b) % Z1-Y1-G1"(~Y2-At)-Y3—A2~·^1 十 A6-Y7&G2-Y8-Z2N—N x—Y5—A4—^A5-T2 N—N (3) Y3—A1-Y2^G1-Y Bu Z1 (4a) + Y6′-(—A6—Y7)jG2—Y8—Z2 ( 4b) % Z1-Y1-G1"(~Y2-At)-Y3—A2~·^1 Ten A6-Y7&G2-Y8-Z2

(D 上述式中,A1~A6、X、Y1~Y8、Qi〜Q4、G1、G2、Z1、Z2、 a、b表示與上述相同的涵義。再者,π為與Y3’反應而 生成Y3的基團,且T2表示與Y6,反應而生成Y6的基團。 例如’1:1、1'2為氫氧基(〇1〇’¥3’、¥6’為羧基((;〇〇11)的 情況,ΤΙ、T2為與Y3, 、Y6,各別反應,而分別生成 Y3[-C(=〇)-〇-] 、 Y6[_〇_c(=〇)_]。 亦即,使肼(或肼1水合物)反應於式(2)所示的化合 ^其次使式:㈣)T2鲁c(蝴4所示的化 :物反應’而得到式(3)所示的中間體後(步驟…藉由使 物, )所不的化合物反應於此化合 物 了件到作為目的之式(π把_ 性對堂从 斤不的化合物(本發明之聚合 注對掌性化合物)(步驟2 )。 步驟1可在適當的有機馨媒中進行。 24 201014862 可使用的有機溶媒可列舉甲醇、乙醇、 醇、正丁醇等醇類、、容棋·_ 醇異丙 二甲鍵、“: 趟、四氫吱喝、1,2'乙二醇 ,一噁烷等醚類溶媒;乙酸乙酯、乙酸 丙酸甲酯等酯類溶據.絮 m 酸丙sa 頸备媒,本、甲笨、二甲苯等芳香族碳化氫 類溶媒;正戊烷、正货孩碳化氫 Ν Ν--曱基甲醯脸70 院等脂肪族碳化氫類溶媒; Ν,Ν 一甲基甲酿胺、[甲基…酮、 胺類溶媒;二甲亞挪墦π ,職一胺寻 f亞砜、環丁碾等的含硫黃類溶媒;以及由 ϋ 這些的2種以上構成的混合溶媒等。 及 :驟1之中’相對於式(2)所示的化合物,肼的使用量 通常為2~10倍的莫耳。 相對於式(2)所示的化合物, T9 a1! rr-n^ioyi 式.1 A2-c(=〇)qi 以及 T2-A5-C(-0)Q4所示的化合 倍的莫耳。式.下〗” 使用量通常分別為〇.5〜5 倍的莫耳式· n_A叫咖所示的化合物以及 T2-A5-C(=0)Q4所示的化人 旳化^物為相同的情況 上也可以。 災用借篁以 步雜1的反應是在杜 圍順利地進行。 c〜使用的溶媒的彿點的溫度範 反應時間是根據反應颊 數小時。 ’、規模k ’然而通常為數分鐘至 如以上所述,可得到含 _ 有式(3)所示的化合物的反應 液。 本發明之中,可以由得 仔幻的反應液之中離析式ί3)所干 的化合物,再將已離析的式( ' 所不的化合物提供以下的步 驟2,也可以不離析式(3)祕_ u 不的化合物’直接將含有式(3) 25 201014862 所示的化合物的反應液提供步驟2。 者,式(3)所示的化合物也可 造。 稽由M下的方法來製 【化10】 Q2-C~A3-Y4-x_Y5_a4_c_Q3 Ο(D In the above formula, A1 to A6, X, Y1 to Y8, Qi to Q4, G1, G2, Z1, Z2, a, and b have the same meanings as described above. Further, π is a reaction with Y3' to generate Y3. a group, and T2 represents a group which reacts with Y6 to form Y6. For example, '1:1, 1'2 is a hydroxyl group (〇1〇'¥3', and ¥6' is a carboxyl group ((;〇〇 In the case of 11), ΤΙ and T2 are respectively reacted with Y3, and Y6, and Y3[-C(=〇)-〇-] and Y6[_〇_c(=〇)_] are respectively generated. The hydrazine (or hydrazine 1 hydrate) is reacted with the compound represented by the formula (2), and the formula (4)) T2 ru c (the chemical reaction shown in the butterfly 4 is obtained) to obtain the formula (3). After the intermediate (step... by means of the substance), the compound which is not reacted with the compound to the object of the formula (the compound of the present invention is not the compound of the present invention) (Step 2) Step 1 can be carried out in an appropriate organic solvent. 24 201014862 Organic solvents which can be used include alcohols such as methanol, ethanol, alcohol, n-butanol, and the like. , ": 趟, tetrahydro hydrazine, 1,2' ethylene glycol, An ether solvent such as monooxane; an ester such as ethyl acetate or methyl propionate; a flocculating m-acrylic sa-neck preparation medium; an aromatic hydrocarbon-based solvent such as benzoyl or xylene; n-pentane正,------------------------------------------------------------------------------------------------------------------------ π , a sulfur-containing yellow solvent such as a sulfoxide or a cyclopentane; and a mixed solvent composed of two or more of these; and: in the first step, 'relative to the formula (2) For the compound, the amount of hydrazine is usually 2 to 10 times the molar amount. Relative to the compound of the formula (2), T9 a1! rr-n^ioyi Formula.1 A2-c(=〇)qi and T2- The compound shown in A5-C(-0)Q4 is the same as the compound shown in the following table. The amount of the compound is usually 〇.5~5 times of the molar type, n_A is the compound shown by the coffee and T2-A5- It is also possible to use C(=0)Q4 for the same person. The reaction of the disaster with the step 1 is carried out smoothly in Duwei. c~ The use of the solvent of the Buddha's point Temperature range reaction time is based on the number of bucculations ', the scale k' is usually, however, several minutes up to the above, and a reaction liquid containing the compound represented by the formula (3) can be obtained. In the present invention, it can be isolated from the reaction liquid. Ί3) The compound to be dried, and the compound of the isolated formula (the following step 2 can be provided, or the compound of the formula (3) secret _ u is not directly isolated) will contain the formula (3) 25 201014862 The reaction solution of the indicated compound is provided in step 2. The compound represented by the formula (3) can also be produced. According to the method of M, [10] Q2-C~A3-Y4-x_Y5_a4_c_Q3 Ο

ο II (2) 1) T1-yiο II (2) 1) T1-yi

(Sa) n-NH2 yQi Q2 ~~' --- T1 2) v /)A5-T2(Sa) n-NH2 yQi Q2 ~~' --- T1 2) v /)A5-T2

H2N—NH2N-N

“卜丫4-^ 〇j (3) N~~N"卜丫4-^ 〇j (3) N~~N

A5-T2 (5b) % (式中,AH5、Y4、Y5、Ql〜Q4、Tl、 同的涵義)。 兴上迷相 亦即,使式(5a)所示的化合物以及式 所示的化合 物依序反應於式(2)所示的化合物,可 合物。 侍到式(3)所示的化 式(5a)以及(5b)所示的化合物可分別藉由使式. rttc〇(=0)Ql^ T2'A5'C(=0)Q4^^^^^^ ^ 其次,藉由使式Ua)所示的化合物以及(4b)所示的化 合物反應於此化合物,可得到作為目的 <八所示的化入 物(本發明的聚合性對掌性化合物)(步驟2)。 σ 使式(4a)所示的化合物以及(处)杯-& , )所不的化合物較佳的 具體例可列舉下述的化合物’當然, 合物。 本發明不限於這些化 26 201014862 【化11】 Ο 〇 η II πA5-T2 (5b) % (where AH5, Y4, Y5, Ql~Q4, Tl, the same meaning). In other words, the compound represented by the formula (5a) and the compound represented by the formula are sequentially reacted with the compound represented by the formula (2), and a compound. The compound represented by the formulas (5a) and (5b) shown in the formula (3) can be respectively obtained by the formula rttc〇(=0)Ql^T2'A5'C(=0)Q4^^^ ^^^ ^ Next, by reacting the compound represented by the formula Ua) and the compound represented by the formula (4b) with the compound, the compound represented by the objective <8 can be obtained (polymerization of the present invention) Compound) (Step 2). σ The preferred compound of the compound represented by the formula (4a) and the compound of the formula (4a) is exemplified by the following compound. The present invention is not limited to these. 26 201014862 [Chemical 11] Ο 〇 η II π

H2〇—C—~C—ο—fcH2)-0—C—(ch2-}-COOH P nH2〇—C—~C—ο—fcH2)-0—C—(ch2-}-COOH P n

Η#』—C—O—fcH 七 0—义》—COOH (式中’ p、q各自獨立表示1〜6的整數。) 步驟2可在適當的有機溶媒中進行。 〇 使用的有機溶媒可列舉,與步驟1可使用而列出的相 同的溶媒。 步驟2之中,相對於式(3)所示的化合物,式:(4a) 以及式(4b)所示的化合物的使用量通常分別為卜3倍的莫 〇 並且,式(4a)所示的化合物以及式(4b)所示的化合物 為相同的情況,使用倍量以上也可以。 % 步驟2的反應是在-1(rc〜使用的溶媒的沸點的溫度範 圍順利地進行。 反應時間是根據反應規模然而通常為數分鐘至 數小時。 反應終了後,進行有機合成化學中通常的後處理操 作,視需要’可藉由施以管柱色層分析、再結晶、蒸餘法 等習知的分離•精製手段,來離析目的物。 目的物的構造’可藉由™光譜、IR光譜、質量光譜 等測定、元素分析等來鑑定。 27 201014862 出發原 式來製造。 料之式(2)所示的化合物 可利用以下所示的方 【化12】 Y4'· -Y5' ⑹ + Q2—c—A3—T3 Ο (7) 〇3_C—A4—T4 II 〇 (8)Η#』—C—O—fcH 七—义——COOH (wherein p and q each independently represent an integer from 1 to 6.) Step 2 can be carried out in a suitable organic solvent.有机 The organic solvent to be used may be the same solvent as that which can be used in the step 1. In the step 2, the compound represented by the formula (4a) and the formula (4b) is usually used in an amount of 3 times that of the compound represented by the formula (3), and is represented by the formula (4a). The compound represented by the formula (4b) and the compound represented by the formula (4b) may be the same or different amounts. % The reaction in step 2 is carried out smoothly at a temperature range of -1 (rc~ the boiling point of the solvent used. The reaction time is usually several minutes to several hours depending on the scale of the reaction. After the completion of the reaction, the organic synthesis chemistry is usually carried out. The treatment operation can be isolated by the conventional separation and purification methods such as column chromatography, recrystallization, and distillation, as needed. The structure of the target can be obtained by TM spectrum and IR spectrum. It is determined by measurement of mass spectrum, elemental analysis, etc. 27 201014862 The original formula is manufactured. The compound shown by formula (2) can be obtained by the following formula: [12] Y4'·-Y5' (6) + Q2 —c—A3—T3 Ο (7) 〇3_C—A4—T4 II 〇(8)

•(上述式中,A3、A4、X、Y4、Y5、Q2、Q3表示與上述 ^同的涵義。再者,T3表示與Y4,反應而生成丫4的基團, 4表示與Y5,反應而生成Y5的基團)。 '即藉由使成為對掌性基的式(6)所示的化合物與式 (7)^. 不的化合物以及式(8)所示的化合物反應,可得到作 為目M a « 的之式(2)所示的化合物。 式(6)所示的化合物的較佳具體例可列舉下述所示的 物。當然,本發明不限於這些化合物。 【化13】 一 28 201014862(In the above formula, A3, A4, X, Y4, Y5, Q2, and Q3 have the same meanings as above. Further, T3 represents a group which reacts with Y4 to form 丫4, and 4 represents a reaction with Y5. And the group of Y5 is generated). By reacting a compound represented by the formula (6) which is a palm group with a compound of the formula (7) and a compound represented by the formula (8), a formula of the form M a « can be obtained. (2) A compound shown. Preferable specific examples of the compound represented by the formula (6) include the following ones. Of course, the invention is not limited to these compounds. [化13] A 28 201014862

OHOH

(式中,LrL4表示與上述相同的涵義)。 再者,式(7)以及式(8)所示的化合物的較佳具體例可 列舉下述所示的化合物。當然,本發明不限於這些化合物。 【化14】(wherein, LrL4 represents the same meaning as described above). Further, preferred examples of the compound represented by the formula (7) and the formula (8) include the compounds shown below. Of course, the invention is not limited to these compounds. 【化14】

29 20101486229 201014862

(式中,表示與上述相同的涵義,q為卩3或^)。 這些化合物大多為習知物質,可藉由習知的方法製造。 2 )聚合性液晶組成物 本發明的聚合性液晶組成物含有本發明的聚合性對掌 性化合物的至少一種以及聚合性液晶化合物的至少一種。 構成本發明的聚合性液晶組成物的聚合性液晶化合物 為,藉由與本發明的聚合性對掌性化合物混合顯現膽固醇 相而獲得。 使用於本發明的組成物的聚合性液晶化合物的具體例 可列舉特開平^-:^0 729號公報、特開平8_1Q487〇號公 報、特開2005一309205號公報、特開2005-263789號公報、 特表2_-533742號公報、特開⑽2_麵32號公報、特 3〇 201014862 開2002-265421號公報、特開昭62-070406號公報、特開 平 11-100575 號公報、PCT/JP2008/057896、特願 2008-92093 號、特願 2008-92162 號、特願 2008-170835 等所記 載的化合物。 本發明的組成物含有上述能夠聚合的液晶化合物的一 種或二種以上以作為必要成份。 本發明的聚合性液晶組成物之中,相對於聚合性液晶 化合物100重量部,聚合性對掌性化合物的配合比例通常 ® 為〇.卜1 00重量部,較佳為〇· 5〜10重量部,更佳為卜8重 量部。 由較有效率地進行聚合反應的觀點看來,本發明的聚 合性液晶組成物之中最好配合聚合起始劑。(wherein, the same meaning as above is indicated, and q is 卩3 or ^). Most of these compounds are conventional materials and can be produced by a conventional method. 2) Polymerizable liquid crystal composition The polymerizable liquid crystal composition of the present invention contains at least one of the polymerizable palmitic compound of the present invention and at least one of the polymerizable liquid crystal compounds. The polymerizable liquid crystal compound constituting the polymerizable liquid crystal composition of the present invention is obtained by mixing a polymerizable palmitic compound of the present invention to reveal a cholesterol phase. Specific examples of the polymerizable liquid crystal compound to be used in the composition of the present invention are disclosed in Japanese Laid-Open Patent Publication No. Hei. No. 2005-263789. Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. 057 896, the compounds described in Japanese Patent Application No. 2008-92093, and the Japanese Patent Application No. 2008-170835. The composition of the present invention contains one or more of the above-mentioned polymerizable liquid crystal compounds as an essential component. In the polymerizable liquid crystal composition of the present invention, the mixing ratio of the polymerizable property to the palm compound is usually 〇. 重量重量, preferably 〇·5 to 10 by weight based on 100 parts by weight of the polymerizable liquid crystal compound. Department, better for Bu 8 weight. From the viewpoint of carrying out the polymerization reaction more efficiently, it is preferred to incorporate a polymerization initiator in the polymerizable liquid crystal composition of the present invention.

使用的聚合起始劑可視使用的聚合性液晶化合物存在 的聚合性基的種類而適當地選擇而使用。例如,聚合性基 為自由&聚合纟、陽冑聚合性的&團以及陰極子聚合性的 基團的話’則最好分別使用自由基聚合起始劑、陽離聚合 起始劑以及陰極子聚合起始劑。 自由基聚合起始劑使用熱自由基產生劑與光自由基產 生劑的任—者皆可,然而使用光自由基起始劑較適合。 光自由基起始劑可列舉香息香、安息香甲醚、安息香 丙鍵等女息香;苯乙_、2,2 —二甲氧基-2-笨基苯乙酮、2,2-二乙氧基-2-笨基苯乙明、U1_二氣苯乙酮、卜經基環己基 笨基甲_ ' 2-曱基_卜[4一(甲硫基)苯基]_2_嗎琳基一卜丙 8¾ 、N W ’ 一 m ,――甲胺基苯乙酮等的苯乙酮;2-甲基蒽醌、卜 31 201014862 氣蒽酿以及2 -戊基葱酿等的蒽酿;2,4-二甲基硫雜蒽酮、 2,4-二乙基硫雜蒽嗣、2-氣硫雜蒽網、2, 4 -二異丙基硫雜 蒽酮等硫雜蒽酮;笨乙酮二甲基縮綱以及苄基二甲基縮酮 等縮酮,二苯基酮、曱基二苯基嗣、4,4 -二氣二笨基酮、 4, 4-雙二乙基胺基二苯基酮、米希勒酮、4-苄基-4-甲基二 苯基硫等的二苯基酮;2, 4, 6-三甲基苄基二苯基氧膦等。 光自由基聚合起始劑的具體例,可列舉例如汽巴精化 (ciba specialty chemicals)公司製造的商品名 : Irgacure907、商品名:Irgacurel84 '商品名:irgacure369、 Q 商品名:Irgacure651 等。 陰離子聚合起始劑例如可列舉烷基鋰化合物、聯苯、 萘、芘等的單鋁鹽或單鈉鹽;二鋰鹽或三鋰鹽等多官能性 起始劑等。 再者’陽離子聚合起始劑例如可列舉硫酸、碟酸、過 氣酸、三氟甲磺酸等的質子酸;三氟化硼、氯化鋁、四氣The polymerization initiator to be used is appropriately selected and used depending on the kind of the polymerizable group which the polymerizable liquid crystal compound to be used. For example, if the polymerizable group is a free & polymeric oxime, an cation-aggregating & group, and a cathodically polymerizable group, it is preferred to use a radical polymerization initiator, a cationic polymerization initiator, and a cathode, respectively. Sub-polymerization initiator. The radical polymerization initiator may be any one of a thermal radical generator and a photoradical generator, but a photoradical initiator is preferably used. The photoradical initiator can be exemplified by a fragrant incense, a benzoin methyl ether, a benzoin-like bond, and the like; phenethyl _, 2,2-dimethoxy-2-styl acetophenone, 2,2-di Ethoxy-2-phenylphenethylamine, U1_dioxaacetophenone, dipyridylcyclohexylamino-[2-indenyl-bu [4-monomethylthio)phenyl]_2 Acetophenone 83⁄4, NW 'm, acetophenone, etc.; acetophenone; 2-methylindole, b 31 201014862 gas brewing and 2-pentyl onion brewing; 2 , 4-dimethylthiazinone, 2,4-diethylthiazepine, 2-thiazepine net, thiazepine such as 2,4-diisopropylthiaxanone; stupid Ketal dimethyl condensate and ketal such as benzyl dimethyl ketal, diphenyl ketone, decyl diphenyl hydrazine, 4, 4 - dioxa diphenyl ketone, 4, 4- bis diethylamine a diphenyl ketone such as bisphenyl ketone, michelone or 4-benzyl-4-methyldiphenyl sulfoxide; 2,4,6-trimethylbenzyldiphenylphosphine oxide or the like. Specific examples of the photoradical polymerization initiator include, for example, a product name: Irgacure 907, trade name: Irgacurel 84 'trade name: ilgacure 369, Q product name: Irgacure 651, manufactured by Ciba Specialty Chemicals Co., Ltd., and the like. The anionic polymerization initiator may, for example, be a monolithium salt or a monosodium salt such as an alkyllithium compound, biphenyl, naphthalene or anthracene; or a polyfunctional initiator such as a dilithium salt or a trilithium salt. Further, the cationic polymerization initiator may, for example, be a protonic acid such as sulfuric acid, a disc acid, a peroxyacid or a trifluoromethanesulfonic acid; or a boron trifluoride, aluminum chloride or tetragas;

化欽、四氣化錫等路易士酸;芳香族鏽鹽或併用芳香族鐵 鹽與還原劑的系列。 這些聚合起始劑可以一種單獨或组合二種以上來使 用。 本發明的聚合性液晶組成物之中,相對於聚合性液晶 化合物1 〇〇重量部,聚合起始劑的配合比例通常為,聚合 起始劑0· 1〜30重量部,較佳為〇· 5~1〇重量部。 再者’進行上述聚合性液晶化合物以及視需要使用的 其他能夠共聚合的單體等的(共)聚合時,也可以視需要存 32 201014862 氧化防止劑等的機能性 在紫外線吸收劑、紅外線吸收劑 化合物。 為了調整表面張力,本發明的聚合性液晶組成物之中 最好配合界面活性劑。該界面活性劑沒有特別限定,缺而 通常最好為非離子界面活性劑。該非離子界面活性劑可使 用市售品’例如分子量數千的寡聚物之非離子界面活性 劑’例如可列舉清美化學(株)製造的KH-40等。本發明的 U聚合性液晶組成物之中,相對於聚合性液晶化合物1〇〇重 ϋ量部’界面活性劑的配合比例通常為0.01〜10重量部,較 佳為0. 1〜2重量部》 將本發明的t合性液晶組成物利用於偏光膜、配向膜 的原料,或者印刷墨水以及塗料、保護膜等的用途時,除 了上述成份以外,也可以視其目的,配合後述的其他能夠 八聚^的單體、金屬、金屬錯合物、染料、顏料、螢光材 料、鱗光材料、平整劑、流變劑、凝膝化㈣、多糖類、紫 ^ 外線吸收劑、紅外線吸收劑、抗氧化劑、離子交換樹脂、 氧化鈦等金屬氧化物等的其他添加劑。本發明的聚合性液 晶組成物之中’相對於聚合性液晶化合物1〇〇重量部,其 他添加劑的配合比例通常各別為0•卜20重量部。 本發明的聚合性液晶組成物通常可藉由使聚合性液晶 化合物、本發明的聚合性對掌性化合物、光聚合起始劑、 非離子界面活性劑以及根據希望的其他添加劑的既定量溶 解於適當的有機溶媒中而調製。 使用的有機溶媒可列舉環戊酮、環己酮、甲基乙基酮 33 201014862 等的酮類;乙酸丁酯、乙酸戊酯等乙酸酯類;氯仿、二氣 曱烧、一氣乙烧等鹵化碳化氫類;ι,2_二甲氧乙烧、1,4-二氧六園、環戊基甲醚、四氫呋鳴、四氳吡喃等醚類等。 如以上所述的方式得到的聚合性液晶組成物可適用於 如後所述的膽固醇液晶層、膽固醇液晶性高分子的製造原 料。 3)液晶性高分子 本發明的液晶性高分子是將本發明的聚合性液晶組成 物(共)聚合而得到的高分子。 在此「(共)聚合」是指,除了一般的(共)聚合反應以 外,也意味著包含(共)交聯反應的廣義的化學反應。 藉由在聚合起始劑的存在下,(共)聚合本發明的聚合 性液晶組成物’可容易地得到本發明的液晶性高分子。得 到的液晶性高分子為膽固醇液晶性高分子。由較有效率地 進行(共)聚合反應的觀點看來,本發明中,最好使用如上 所述的聚合起始劑,特別是光聚合起始劑。以下,說明使 用上述聚合性液晶组成物的態樣。 具體而言’將本發明的聚合性液晶組成物塗佈於例如 藉由施以上述的配向處理的方法得到的具有配向機能的支 擇體上,在維持膽固醇的狀態均一地配向,且聚合而得到 本發明的液晶性高分子。 使用的支撐體,不論是有機、無機,可使用習知慣用 的材質的基板。該基板的材料可列舉聚環烯烴[例如, ΖΕ0ΝΕΧ、ZE0Z0R(登錄商標;日本ΖΕΟΝ公司製造)]、 34 201014862 ART0N (登錄商標;JSR公司製造)以及APEL(登錄商標;三 井化學公司製造)、聚對笨二曱酸乙二醇酯、聚破酸酯、聚 醯亞胺、聚醯胺、聚曱基丙烯酸曱酯、聚苯乙烯、聚氣乙 烯、聚四氟乙烯、纖維素、三醋酸纖維素、聚醚颯、矽、 玻璃、方解石等。基板的形狀除了平板以外,也可以具有 曲面。這些基板也可以視需要具有電極層、反射防止機能、 反射機能。 上述方法之中,為了形成一致的配向狀態,使用一般 的扭轉向列(TN)元件或超扭轉向列(STN)元件的之賦予預 傾角的聚醯亞胺薄膜的話,可容易進行聚合性液晶化合物 的配向狀態的控制。 通常,使液晶化合物與具有配向機能的支撐體接觸 時,液晶化合物在支撐體表面是沿著配向處理支撐體的方 向配向。液晶化合物不論是與支撐體表面水平地配向,或 者傾斜或垂直配向,受到往支撐體表面的配向處理方法的 ^ 影響很大。 例如’如果在支撐體上設置使用於水平切換(Ips)方式 的液晶顯示元件之類的預傾角極小的配向膜的話,可得到 幾乎水平地配向的聚合性液晶層。 再者’如果在支撐體上設置使用於TN型液晶顯示元件 之類的配向膜的話,可得到僅小幅配向傾斜的聚合性液晶 層,如果在支撐體上設置使用於STN型液晶顯示元件之類 的配向膜的話,可得到大幅配向傾斜的聚合性液晶層。 使本發明的聚合性液晶組成物與具有預傾角的之具有 35 201014862 水平配向機能的支撐體接觸時’可得到從支撐體表面到空 氣界面附近一致或連續地變化角度而傾斜配向的光學非等 向體。 再者,在具有分子内光二量化反應的官能基的有機薄 膜、具有異性化的官能基的有機薄膜(以下稱「光配向膜」) 上使用照射偏光或非偏光的方法等(「光配向法」)的話, 也可製作分佈著呈圖案狀而不同配向方向區域的基板。 首先,在設置有光配向膜的支撐體上照射具有光配向 膜的吸收帶的波長的光’以準備可得到一致配向的支樓 體。之後,在該支撐體上覆蓋罩幕,再從罩幕上照射與具 有光配向的吸收波長第1照射不同狀態的光,例如偏光狀 態不同光或照射角度以及方向不同的光,可得到僅在照射 部分,具有與第1照射得到的部分具有不同配向機能。 如果使聚合性液晶組成物接觸如上所述得到的呈圖案 狀分佈著配向機能不同的區域的支撐體的話,可根據支撐 體的配向機能,而分佈呈圖案狀配向方向不同的區域。在 此狀態藉由光照射而進行聚合的話,可得到具有配向圖案 的液晶性兩分子。 , 特別是,如果使用分佈著呈圖案狀而配向方向不同的 區域之具有略為水平配向機能的支撐體來作為支撐體時, 可得到特別適用於相位差膜的液晶性高分子膜。 此外,得到配向圖案的方法,可採用AFM(原子間力顯 微鏡)的觸針摩擦配向膜的方法、蝕刻光學非等向體方法等 不使用光配向膜的方法,然而利用光配向膜的方法簡便, 36 201014862 所以較佳。 在支撐體上塗佈本發明的聚合性液晶組成物的方法, 可列舉線棒塗佈、旋轉塗佈、滾輪塗佈、凹印塗佈、噴灑 塗佈、狹缝塗佈、封蓋塗佈、浸潰法等習知的塗佈方法。 此時’為了提高塗工性,也可以在本發明的聚合性液晶組 成物之中添加習知慣用的有機溶媒。此情況,將本發明的 聚合性液晶組成物塗佈於支撐體上之後,以自然乾燥、加 熱乾燥、減壓乾燥、減壓加熱乾燥等去除有機溶媒較佳。 ® 塗佈後,最好是使本發明的聚合性液晶組成物中的液 晶化合物維持在膽固醇相的狀態均一地配向。具體而言, 藉由進行促進液晶的配向的加熱處理,可更促進配向。加 熱處理的溫度通常為50〜15(rc,較佳為7〇~14〇t,加熱處 理的時間通常為〇. 5〜15分鐘,較佳為2〜10分鐘。 熱處理法較佳例如為在支撐體上塗佈本發明的聚合性 液晶組成物之後,加熱至該液晶組成物的c(固相)_N(列向 ^ 相)轉移溫度(以下簡稱「C-N轉移溫度」)以上,使該聚合 性液晶組成物成為液晶相或等方相液體狀態。之後,視需 要慢慢冷卻,以顯現出膽固醇相。此時,保持呈現一度液 b曰相的溫度’使液晶相的區塊(d〇ma in)充分地成長,以成 為早一區塊較佳。 再者’在支撐體上塗佈本發明的聚合性液晶組成物後 也可以施以加熱處理,以在顯現本發明的聚合性液晶組成 物的膽固醇相的溫度範圍内,將溫度維持固定時間。 加熱溫度過高時’有引起聚合性液晶組成物不良的聚 3Ί 201014862 合反應而劣化之虞。再者,過度冷卻時,會引起聚合性液 晶組成物相分離’且結晶析出,顯現出層列相之類的高次 液晶相,具有使配向處理成為不可能。 藉由如上所述的加熱處理,比起只有單純塗工方法, 可製作配向缺陷少的均質的液晶性高分子膜。 再者’進行如上所述的均質配向處理後,冷卻直到不 會引起液晶相引起相分離的溫度,亦即成為過冷卻狀態, 且藉由在該溫度之中在使液晶相配向的狀態下聚合,可得 到配向秩序高且透明性良好的液晶性高分子。 使聚合性液晶組成物聚合的方法,可列舉照射活性能 量線的方法、熱聚合法等,然而不需要加熱而在室溫進行 反應後照射活性能量線較佳。特別是,由於操作簡便,所 以照射紫外線等的光的方法較佳。 照射的溫度為可將聚合性液晶組成物維持液晶相的溫 度為了避免引發聚合性液晶化合物或聚合性液晶組成物 的熱聚合,較佳為儘可能在30t以下。並且,聚合性液晶 化合物以及聚合性液晶組成物通常在升溫過程中,會從d 轉移溫度在N(向列相)-1(等向性液體相)轉移溫度(以下, 簡稱「N-丨轉移溫度」)範圍内顯示液晶相。另一方面,在 降溫過程中’由於採用熱力學上非平衡狀態,所以即使在 C-N轉移溫度以下’有*凝固而維持液晶狀態的情況。此 狀態稱為過冷卻狀態。本發明之中,包括過冷卻狀態的聚 合性液晶化合物以及聚合性液晶組成物維持於液晶相的狀 態。紫外線照射強度通常為1W/m2〜1〇kw/m2的範圍,較佳為 38 201014862 5W/m2〜2kW/m2的範圍。 再者,使用罩幕以紫外線僅照射特定的部分聚合後, 以電場、磁場或溫度使該未聚合的部分的配向狀態變化, 之後聚合該未聚合部分時,可得到具有不同配向方向的複 數個區域的液晶高分子膜。 再者,使用罩幕僅以紫外照射特定的部分聚合時,以 電場。磁場或溫度預先規制配向,即使藉由從維持此狀態 直接由罩幕上照射光而聚合’也可得到具有不同配向方向 的複數個區域的液晶性高分子膜。 (共)聚合本發明的聚合性液晶組成物所得到的液晶高 分子,可以從支撑體剝離以單體使用,也可以不從支推體 剝離直接作為光學非等向體使用。 特別是,由於(共)聚合本發明的聚合性液晶組成物得 到的液晶性高分子膜為膽固醇液晶膜,具有極高的反射 率’所以適用於液晶顯示元件之中的偏光子。 除了此外’藉由積層法使如上所述的液晶性高分子膜 複數積層,且藉由適當地選擇所選擇的液晶性高分子的選 擇波長,可得到遍及整個可見光譜的光的多層偏光子(參照 EP0720041 號公報)。 再者’也可使用組合適當的化合物以及加工條件的所 明廣域帶偏光子(broad-band polarizer),來取代如上所 述的多層偏光子。此目的之實施方法可列舉w〇98/08135號 小冊子、EP0606940 號公報、GB2312529 號公報、ff〇96/08l35 小冊子等記載的方法。 39 201014862 並且,可使用本發明的聚合性液晶組成物製造彩色濾 光片。因此’藉由業者慣用的塗佈方法施予必要的波長。 再者,可利用膽固醇液晶的熱變色性。藉由溫度的調 整,膽固醇的色彩會由紅色經由綠色推移至藍色。可使用 罩幕在定義特定的頻帶的溫度聚合。 如上所述的得到的液晶性高分子的數值平均分子量較 佳為500〜500, 000,更佳為5, 〇〇〇〜300, 000。如果落在上述 數值平均分子量的範圍内,可得到高膜硬度,處理性也良 好,所以較佳》液晶性高分子的數值平均分子量可將單分 散的聚乙烯作為標準試料,以四氟乙烯(TFH)作為溶離液, 藉由凝膠滲透層析(GPC)測定: 本發明的液晶性高分子膜可推定在分子内交聯點平均 地存在。由於可(共)聚合而得到本發明的聚合性液晶化合 物,所以交聯效率高,且硬度良好。 本發明的液晶性高分子利用其配向性以及折射率、介 電率、磁化率等物理性質的異向性,可使用來作為相位差 板、液晶顯示元件用配向膜、偏光板、視角擴大板、彩色 濾光片、低通濾光片、光偏光稜鏡、各種濾光片等光學非 等向體的構成材料。 4)光學非等向體 本發明的第4觀點可提供以本發明的液晶性高分子作 為構成材料的光學非等向體。 本發明的光學非等向體可列舉相位差板、液晶顯示元 件用配向膜、偏光板、視角擴大板、彩色濾光片、低通濾 40 201014862 光片、光偏光稜鏡、各種濾光片等。 本發明的光學非等向體是以聚合本發明的聚合性液曰 組成物所得到的液晶性高分子作為構成材料,所以具有均 一高品質的液晶配向性。 實施例 以下利用實施例以詳細地說明本發明,然而本發明不 限於此。並且,部及%不限於重量基準。 並且,管柱層析法使用的展開溶媒比(括弧内所干认 '丨、π >容 媒比)為容積比。 (實施例1)聚合性對掌性化合物(1-1)的合成 【化15】A series of Lewis acid, such as Huachin, Siqihua, etc.; aromatic rust salt or a combination of aromatic iron salts and reducing agents. These polymerization initiators may be used singly or in combination of two or more. In the polymerizable liquid crystal composition of the present invention, the mixing ratio of the polymerization initiator to the weight portion of the polymerizable liquid crystal compound is usually from 0 to 1 to 30 parts by weight of the polymerization initiator, preferably 〇· 5~1〇 weight. In addition, when (co)polymerization of the above-mentioned polymerizable liquid crystal compound and other copolymerizable monomers to be used, etc., may be carried out as needed, the functional properties such as the oxidation inhibitor may be stored in the ultraviolet absorber or the infrared absorption. Compound. In order to adjust the surface tension, it is preferable to mix a surfactant in the polymerizable liquid crystal composition of the present invention. The surfactant is not particularly limited, and is usually preferably a nonionic surfactant. For the nonionic surfactant, for example, a nonionic surfactant such as an oligomer having a molecular weight of several thousands can be used, for example, KH-40 manufactured by Seimi Chemical Co., Ltd., and the like. 1〜2重量部。 In the U polymerizable liquid crystal composition of the polymerizable liquid crystal compound 1 〇〇 ϋ ' ' ' ' 界面 ' ' ' ' ' ' ' 界面 界面 0.01 0.01 0.01 0.01 0.01 When the t-type liquid crystal composition of the present invention is used for a material of a polarizing film or an alignment film, or a printing ink, a paint, a protective film, or the like, in addition to the above components, other substances described later may be blended depending on the purpose. Octagonal monomer, metal, metal complex, dye, pigment, fluorescent material, spheroidal material, leveling agent, rheological agent, condensed knee (4), polysaccharide, purple ^ external absorbent, infrared absorbing agent Other additives such as antioxidants, ion exchange resins, and metal oxides such as titanium oxide. In the polymerizable liquid crystal composition of the present invention, the blending ratio of the other additives to the weight portion of the polymerizable liquid crystal compound is usually 0 to 20 parts by weight. The polymerizable liquid crystal composition of the present invention can be usually dissolved in a predetermined amount by a polymerizable liquid crystal compound, a polymerizable palmitic compound of the present invention, a photopolymerization initiator, a nonionic surfactant, and other additives as desired. Modulated in a suitable organic solvent. The organic solvent to be used may, for example, be a ketone such as cyclopentanone, cyclohexanone or methyl ethyl ketone 33 201014862; an acetate such as butyl acetate or amyl acetate; or a halogenated product such as chloroform, dioxane or Yiqi. Hydrocarbons; ethers such as i, 2, dimethoxyethane, 1,4-dioxane, cyclopentyl methyl ether, tetrahydrofuran, tetraterpene pyran and the like. The polymerizable liquid crystal composition obtained as described above can be suitably used as a raw material for producing a cholesteric liquid crystal layer or a cholesteric liquid crystalline polymer as described later. 3) Liquid crystalline polymer The liquid crystalline polymer of the present invention is a polymer obtained by (co)polymerizing the polymerizable liquid crystal composition of the present invention. Here, "(co)polymerization" means a generalized chemical reaction including a (co)crosslinking reaction in addition to a general (co)polymerization reaction. The liquid crystalline polymer of the present invention can be easily obtained by (co)polymerizing the polymerizable liquid crystal composition of the present invention in the presence of a polymerization initiator. The obtained liquid crystalline polymer is a cholesteric liquid crystalline polymer. From the viewpoint of carrying out the (co)polymerization reaction more efficiently, in the present invention, it is preferred to use a polymerization initiator as described above, particularly a photopolymerization initiator. Hereinafter, the aspect in which the above polymerizable liquid crystal composition is used will be described. Specifically, the polymerizable liquid crystal composition of the present invention is applied to a selective body having an alignment function obtained by a method of the above-described alignment treatment, and is uniformly aligned in a state in which cholesterol is maintained, and is polymerized. The liquid crystalline polymer of the present invention is obtained. The support used may be a substrate of a conventional material, whether organic or inorganic. The material of the substrate may, for example, be a polycycloolefin (for example, ΖΕ0ΝΕΧ, ZE0Z0R (registered trademark; manufactured by Nippon Paint Co., Ltd.), 34 201014862 ART0N (registered trademark; manufactured by JSR Corporation), and APEL (registered trademark; manufactured by Mitsui Chemicals Co., Ltd.), For stearic acid ethylene glycol ester, polycarboxylate, polyimide, polyamine, decyl acrylate, polystyrene, polyethylene, polytetrafluoroethylene, cellulose, triacetate , polyether oxime, bismuth, glass, calcite, etc. The shape of the substrate may have a curved surface in addition to the flat plate. These substrates may have an electrode layer, a reflection preventing function, and a reflecting function as needed. Among the above methods, in order to form a uniform alignment state, a polyimide film having a pretilt angle imparted to a general twisted nematic (TN) element or a super twisted nematic (STN) element can be easily used. Control of the alignment state of the compound. Usually, when the liquid crystal compound is brought into contact with a support having an alignment function, the liquid crystal compound is aligned on the surface of the support along the direction of the alignment treatment support. The liquid crystal compound is highly affected by the alignment treatment to the surface of the support, whether it is aligned horizontally with the surface of the support or obliquely or vertically. For example, when an alignment film having a small pretilt angle such as a liquid crystal display element of a horizontal switching (Ips) type is provided on a support, a polymerizable liquid crystal layer which is almost horizontally aligned can be obtained. Further, if an alignment film for a TN type liquid crystal display element is provided on a support, a polymerizable liquid crystal layer which is only slightly tilted obliquely can be obtained, and if it is provided on a support for use in an STN type liquid crystal display element or the like In the case of the alignment film, a polymerizable liquid crystal layer having a large alignment tilt can be obtained. When the polymerizable liquid crystal composition of the present invention is brought into contact with a support having a pretilt angle of 35 201014862 horizontal alignment function, an optical non-equal can be obtained which is inclined or uniformly changed from the surface of the support body to the vicinity of the air interface. To the body. In addition, a method of irradiating polarized light or non-polarizing light is used for an organic thin film having a functional group having a functional group of intramolecular photosecondization reaction and an organic thin film having an anisotropic functional group (hereinafter referred to as "photoalignment film") ("optical alignment method" In addition, a substrate in which a pattern and a different alignment direction region are distributed may be produced. First, light having a wavelength of an absorption band having a photo-alignment film is irradiated onto a support provided with a photo-alignment film to prepare a support structure in which a uniform alignment can be obtained. Thereafter, the support is covered with a mask, and light of a state different from the first wavelength of the absorption wavelength having the light distribution is irradiated from the mask, for example, light having a different polarization state or light having an irradiation angle and a direction is obtained only in the light. The irradiated portion has a different alignment function from the portion obtained by the first irradiation. When the polymerizable liquid crystal composition is brought into contact with the support body having the pattern-distributed regions in which the alignment functions are different as described above, the regions having different pattern alignment directions can be distributed depending on the alignment function of the support. When polymerization is carried out by light irradiation in this state, two molecules having liquid crystallinity having an alignment pattern can be obtained. In particular, when a support having a slightly horizontal alignment function in a pattern having a different alignment direction is used as a support, a liquid crystalline polymer film which is particularly suitable for a retardation film can be obtained. Further, as a method of obtaining an alignment pattern, a method of rubbing an alignment film by a stylus of an AFM (atomic force microscope), a method of etching an optical anisotropic method, or the like without using a photo-alignment film may be employed, but a method using a photo-alignment film is simple. , 36 201014862 So it is better. The method of applying the polymerizable liquid crystal composition of the present invention to a support may be, for example, wire bar coating, spin coating, roller coating, gravure coating, spray coating, slit coating, or cap coating. A conventional coating method such as a dipping method. In this case, a conventional organic solvent may be added to the polymerizable liquid crystal composition of the present invention in order to improve the coating property. In this case, after the polymerizable liquid crystal composition of the present invention is applied onto a support, it is preferred to remove the organic solvent by natural drying, heating and drying, drying under reduced pressure, heating under reduced pressure, and the like. After the application, it is preferred that the liquid crystal compound in the polymerizable liquid crystal composition of the present invention is uniformly aligned in a state of maintaining the cholesterol phase. Specifically, the alignment treatment can be further promoted by performing heat treatment for promoting the alignment of the liquid crystal. The heat treatment temperature is usually 50 to 15 (rc, preferably 7 to 14 Torr, and the heat treatment time is usually 〇 5 to 15 minutes, preferably 2 to 10 minutes. The heat treatment method is preferably, for example, After applying the polymerizable liquid crystal composition of the present invention to the support, the liquid crystal composition is heated to a c (solid phase)_N (column phase) transfer temperature (hereinafter referred to as "CN transfer temperature") or higher to cause the polymerization. The liquid crystal composition becomes a liquid crystal phase or an iso-phase liquid state. Thereafter, it is slowly cooled as needed to reveal a cholesterol phase. At this time, the temperature at which the liquid phase b一 phase is maintained is made 'the liquid crystal phase block (d〇 Ma in) is sufficiently grown to be better in the early block. Further, after the polymerizable liquid crystal composition of the present invention is applied onto the support, heat treatment may be applied to visualize the polymerizable liquid crystal of the present invention. In the temperature range of the cholesterol phase of the composition, the temperature is maintained for a fixed period of time. When the heating temperature is too high, the polycondensation of the polymerizable liquid crystal composition may be deteriorated by the reaction. In addition, when excessively cooled, it may cause Polymeric liquid The crystal composition is phase-separated and crystallized to form a high-order liquid crystal phase such as a smectic phase, which makes it impossible to perform the alignment treatment. The heat treatment as described above can be produced by a simple coating method. A homogeneous liquid crystalline polymer film having a small amount of alignment defects. Further, after performing the homogeneous alignment treatment as described above, it is cooled until a temperature at which the liquid crystal phase does not cause phase separation, that is, a supercooled state, and In the state in which the liquid crystal phase is aligned, a liquid crystal polymer having a high alignment order and good transparency can be obtained. A method of polymerizing the polymerizable liquid crystal composition includes a method of irradiating an active energy ray, and a thermal polymerization method. However, it is preferable to irradiate the active energy ray after the reaction at room temperature without heating, and in particular, since it is easy to handle, it is preferable to irradiate light such as ultraviolet ray. The irradiation temperature is such that the polymerizable liquid crystal composition can be maintained. The temperature of the liquid crystal phase is preferably as low as 30 t or less in order to avoid thermal polymerization of the polymerizable liquid crystal compound or the polymerizable liquid crystal composition. Further, the polymerizable liquid crystal compound and the polymerizable liquid crystal composition usually have a transfer temperature from the d (nematic phase)-1 (isotropic liquid phase) from the d transfer temperature during the temperature rise (hereinafter, simply referred to as "N-丨 transfer" In the temperature range, the liquid crystal phase is displayed. On the other hand, during the cooling process, 'the thermodynamically unbalanced state is used, so even if it is below the CN transfer temperature, the liquid crystal state is maintained by solidification. This state is called supercooling. In the present invention, the polymerizable liquid crystal compound and the polymerizable liquid crystal composition in a supercooled state are maintained in a liquid crystal phase. The ultraviolet irradiation intensity is usually in the range of 1 W/m 2 to 1 〇 kw/m 2 , preferably 38. 201014862 The range of 5W/m2 to 2kW/m2. Further, after the specific portion is polymerized by ultraviolet rays using a mask, the alignment state of the unpolymerized portion is changed by an electric field, a magnetic field or a temperature, and then the unpolymerized portion is polymerized. At this time, a liquid crystal polymer film having a plurality of regions having different alignment directions can be obtained. Further, when a mask is used to irradiate only a specific portion of the ultraviolet light, an electric field is applied. The magnetic field or the temperature is pre-regulated, and even if it is polymerized by directly irradiating light from the mask from this state, a liquid crystal polymer film having a plurality of regions having different alignment directions can be obtained. The liquid crystal polymer obtained by polymerizing the polymerizable liquid crystal composition of the present invention may be used as a monomer by being peeled off from the support, or may be used as an optical anisotropic body without being peeled off from the support. In particular, since the liquid crystalline polymer film obtained by (co)polymerizing the polymerizable liquid crystal composition of the present invention is a cholesteric liquid crystal film and has an extremely high reflectance, it is suitable for use as a polarizer in a liquid crystal display device. In addition, the liquid crystal polymer film as described above is laminated in a plurality of layers by a lamination method, and by selecting a selected wavelength of the selected liquid crystalline polymer, a multilayer polarizer of light throughout the visible spectrum can be obtained ( Refer to EP0720041). Further, it is also possible to use a broad-band polarizer in combination with an appropriate compound and processing conditions in place of the multilayer polarizer as described above. The method of the present invention can be exemplified by the methods described in WO 9808135, EP 0606940, GB2312529, ff〇96/08l35, and the like. 39 201014862 Further, a color filter can be produced using the polymerizable liquid crystal composition of the present invention. Therefore, the necessary wavelength is applied by a coating method conventionally used by the industry. Furthermore, the thermochromism of the cholesteric liquid crystal can be utilized. By adjusting the temperature, the color of the cholesterol changes from red to blue through the green. A mask can be used to define temperature aggregation for a particular frequency band. The liquid crystalline polymer obtained as described above preferably has a numerical average molecular weight of 500 to 500,000, more preferably 5, 〇〇〇 to 300,000. If it falls within the above range of the numerical average molecular weight, high film hardness can be obtained, and the handleability is also good. Therefore, it is preferred that the numerical average molecular weight of the liquid crystalline polymer can use monodisperse polyethylene as a standard sample and tetrafluoroethylene (for tetrafluoroethylene). TFH) As a solution, it is measured by gel permeation chromatography (GPC): The liquid crystalline polymer film of the present invention can be estimated to exist evenly at intramolecular crosslinking points. Since the polymerizable liquid crystal compound of the present invention can be obtained by (co)polymerization, the crosslinking efficiency is high and the hardness is good. The liquid crystalline polymer of the present invention can be used as a phase difference plate, an alignment film for a liquid crystal display element, a polarizing plate, and a viewing angle expansion plate by utilizing the anisotropy of the physical properties such as the alignment property and the refractive index, the dielectric constant, and the magnetic susceptibility. A constituent material of an optical anisotropic body such as a color filter, a low-pass filter, a photo-polarized iridium, and various filters. 4) Optical anisotropy According to a fourth aspect of the present invention, an optical anisotropic body comprising the liquid crystalline polymer of the present invention as a constituent material can be provided. The optical anisotropic body of the present invention includes a retardation plate, an alignment film for a liquid crystal display element, a polarizing plate, a viewing angle expansion plate, a color filter, a low-pass filter 40 201014862, a light polarizing plate, and various filters. Wait. The optical anisotropic body of the present invention has a liquid crystal polymer obtained by polymerizing the polymerizable liquid hydrazine composition of the present invention as a constituent material, and therefore has a uniform high-quality liquid crystal alignment property. EXAMPLES Hereinafter, the present invention will be described in detail by way of examples, but the invention is not limited thereto. Further, the parts and % are not limited to the weight basis. Further, the developed solvent ratio (the ratio of 丨, π > media ratio in the brackets) used for column chromatography is a volume ratio. (Example 1) Synthesis of polymerizable palmitic compound (1-1) [Chemical 15]

化合物(I -1) % 步驟1 :中間體(a)的合成 【化16】 /COOCH3Compound (I -1) % Step 1: Synthesis of intermediate (a) [Chemical 16] /COOCH3

OHC—^ OH 中間體(a) 在備有冷卻器、溫度計以及滴下漏斗的4 口反應器、 氮氣流中將5-甲醯基水楊酸15g(〇. 〇9m〇i)、甲 14· 5g(0.45mol)、4-(二曱基胺基)吡啶溶解於200ml的四 昇吱喃(以下簡稱為「THF」)。在室溫下利用滴下漏斗慢慢 41 201014862 地加入已溶於l〇〇ml的THF的二環已基碳二亞胺 37.3g(0.18m〇l)。之後,在室溫下進行6小時反應。反應 終了後、減壓過濾後’在減壓下利用旋轉蒸發器德去THF 以得到黃色油狀物。藉由碎膠管柱層析法(正己烷:THF = 9 : i 精製此黃色油狀物,得到13. 4g的中間體(a)的白色固體 (產率:82· 4%)。構造是以1H-NMR鑑定。 (中間體(a)的1H-NMR資料) H-NMR(500MHz, CDCI3, TMS, δ ppm) : li 36(s 1H) ' 9.88(s,lH)、8.39(s,lH)、8.00(d,1H,j = 9 〇Hz)、7 n(d, 1H, J=9.0Hz) 、 4.01(s, 3H)。 步驟2 :中間體(b)的合成 【化17】 oHc-Q-coq, hs * ooc-^_y-cH〇 中間體(b) 在備有溫度計的4 口反應器、氮氣流中,將對苯二甲 酸 86.3g(0.57mol)、異山梨糖醇 40g(0 23m〇1)、4 (二甲 基胺基)吡啶7 〇g(〇 〇57]n〇1)溶解於65〇mi的N—甲基吡咯 烧嗣。在水浴下,慢慢地投入卜乙基+(3-二甲基胺基丙 基)碳醯二亞胺鹽酸鹽(WSC)110.2g(0.57ffl〇l)於此溶液 中。德,hOHC—^ OH Intermediate (a) In a 4-reactor equipped with a cooler, a thermometer, and a dropping funnel, 15 g of methylmercapto salicylic acid (〇. 〇9m〇i), A14 5 g (0.45 mol) and 4-(didecylamino)pyridine were dissolved in 200 ml of four liters of oxime (hereinafter referred to as "THF"). 37.3 g (0.18 m〇l) of dicyclohexylcarbodiimide dissolved in 1 ml of THF was added at room temperature using a dropping funnel slowly. Thereafter, the reaction was carried out for 6 hours at room temperature. After the completion of the reaction, the mixture was filtered under reduced pressure. The yellow oil was purified by a sep. column chromatography (hexane: THF = 9: i) to give 13.4 g of Intermediate (a) as a white solid (yield: 82. 4%). Identification by 1H-NMR. (1H-NMR data of intermediate (a)) H-NMR (500 MHz, CDCI3, TMS, δ ppm): li 36(s 1H) ' 9.88 (s, lH), 8.39 (s, lH) ), 8.00 (d, 1H, j = 9 〇 Hz), 7 n (d, 1H, J = 9.0 Hz), 4.01 (s, 3H). Step 2: Synthesis of intermediate (b) [Chem. 17] oHc -Q-coq, hs * ooc-^_y-cH〇 intermediate (b) 86.3 g (0.57 mol) of terephthalic acid and 40 g of isosorbide in a nitrogen reactor equipped with a thermometer (0 23m〇1), 4 (dimethylamino)pyridine 7 〇g(〇〇57]n〇1) dissolved in 65〇mi of N-methylpyrrole. Slowly put in a water bath Butyl + (3-dimethylaminopropyl) carbodiimide hydrochloride (WSC) 110.2 g (0.57ffl 〇l) in this solution.

在至溫下進行15個小時反應。反應終了後將反 應液投入水Φ Q | T ’且利用乙酸乙酯500ml進行2次抽出。藉 由刀液操作去除水層,且利用無水硫酸鎂乾燥得到的乙酸 乙醋層之播 欠’以減壓過濾去除硫酸鎂。在減壓下以旋轉蒸 42 201014862 •發器濃縮乙酸乙酯層以得到淡黃色油狀物。藉由碎膠管柱 層析法(正己烷:THF = 3:2)精製此淡黃色油狀物,得到38g 的中間體(b)的白色固體(產率:40.3%)。構造是以1H-NMR 鑑定。 (中間體(b)的1H-NMR資料) 'H-NMRCSOOMHz, CDCla, TMS, δ ppm) : 10. 13(s, 1H) ' l〇.ll(s, 1H) ' 8.26(d, 2H, J = 8. 0Hz) ' 8.19(d, 2H, J = 8.0Hz) ' 8.00(d, 2H, J = 8.0Hz)> 7.97(d, 2H, J = 8.〇Hz) > ^ 5. 53(s,1H)、5. 48(q, 1H’ J = 5. 0Hz,J = 10. 5Hz)、5. 12(t, 1H, J = 5. 0Hz)'4.72(d, 1H, J = 5. 0Hz)' 4. 15-4.10(m, 4H) 〇 步驟3 :中間體(c)的合成 【化18】The reaction was carried out for 15 hours at the temperature. After the completion of the reaction, the reaction solution was poured into water Φ Q | T ' and extracted twice with 500 ml of ethyl acetate. The aqueous layer was removed by a knife-water operation, and the resulting acetic acid layer was dried under anhydrous magnesium sulfate. The ethyl acetate layer was concentrated by rotary evaporation under reduced pressure to give a pale yellow oil. The pale yellow oil was purified by EtOAc (EtOAc: EtOAc: EtOAc) The structure was identified by 1H-NMR. (1H-NMR data for intermediate (b)) 'H-NMRCSOOMHz, CDCla, TMS, δ ppm) : 10. 13(s, 1H) ' l〇.ll(s, 1H) ' 8.26(d, 2H, J = 8. 0Hz) ' 8.19(d, 2H, J = 8.0Hz) ' 8.00(d, 2H, J = 8.0Hz)> 7.97(d, 2H, J = 8.〇Hz) > ^ 5. 53(s,1H), 5.48(q, 1H' J = 5. 0Hz, J = 10. 5Hz), 5. 12(t, 1H, J = 5. 0Hz) '4.72(d, 1H, J = 5. 0Hz)' 4. 15-4.10(m, 4H) 〇Step 3: Synthesis of intermediate (c) [Chem. 18]

中間體(a)8. 2g(0. 〇46m〇l)投入此溶液中,且在室溫下攪拌 30分鐘。之後,將中間體(b)9 3g(〇 〇23m〇1)的溶解於Μ" 的THF,接著投入而進行4小時室溫反應。將析出的結晶 過濾再以乙醇沖洗,而得到含中間體(c)的黃色固體9. 〇g。 由於可使用於精製的溶劑的溶解度低,精製有困難,所以 將含中間體(c)的黃色固體直接使用於以下的步驟。 43 201014862 步驟4:聚合性對掌性化合物(卜丨)的合成 在備有溫度計的4 口反應器、氮氣流中,將之前步驟 3合成的含中間體(c)的黃色固體7〇8、2_丙稀醯氧乙基琥 珀酸 4. 6g(21. 3mmol)、4-(二甲基胺基)吡啶 〇· 26g (2. lmmol)溶解於2〇〇ml的N,N-二甲基曱醯胺(以下簡稱為 「DMF」)。在室溫下加入4. lg(21 4μ〇1)的卜乙基一(3_ 二甲基胺基丙基)碳醯二亞胺鹽酸鹽(wsc)於此溶液中。之 後,在室溫下進行18個小時反應。反應終了後將反應液投 入水中’且利用乙酸乙醋2〇〇ml進行2次抽出。藉由分液 操作去除水層,且利用無水硫酸鎂乾燥得到的乙酸乙酯層 之後進行過濾以去除硫酸鎂。以旋轉蒸發器濃縮乙酸乙 S曰層以得到淡黃色油狀物。藉由矽膠管柱層析法(正己烷: THF~5 : 5)精製淡黃色油狀物’成為淡黃色固體,得到2. 3g 的聚合性對掌性化合物(1_丨)。構造是以lH_NMR鑑定。 (聚合性對掌性化合物(卜丨)的lH_NMR資料) ^-NMRCBOOMHz, CDCh, TMS, 5 ppm) : 8.71(s, 1H) ^ 8-69(s,lH)、8.68(s, lH)、8.68(s,lH)、8.48-8.47(m, 2H)、8.18(d, 2H, J = 8.5Hz) ^ 8. 12-8. 07(m, 4H)、 7*96'7.92(m, 4H) > 7. 24(dd, 2H, J = 1.5Hz, J = 8. 5Hz) ^ 6-44(d(i, 2H, J = l. 3Hz, J = 17.3Hz) ' 6. 14(dd, 2H, 5Hz, 17.3Hz)、5. 86(dd, 2H, J = l.3Hz, J = 10.5Hz)、 5.53(s,1H)、5.47(q、1H, J = 5. 0Hz, J = l〇· 5Hz)、5. 12(t, 1H,J = 5.0Hz)、4.73(d, 1H, J = 5.〇Hz)、4.39(s, 8H)、 4· 15-4· 14(m,2H)、4. ll(d,2H,J = 5. 0Hz)、3. 92(s,6H)、 44 201014862 3.02(t, 4H, J=7.〇H,).2.83(t5 4Rj J = ? 〇Hz) (實施例2)聚合性對掌性化合物(i_2)的 【化19】Intermediate (a) 8. 2 g (0. 〇 46 m〇l) was charged to this solution, and stirred at room temperature for 30 minutes. Thereafter, 9 g of the intermediate (b) (〇23m〇1) was dissolved in THF of Μ", and then the reaction was carried out for 4 hours at room temperature. The precipitated crystals were filtered and washed with ethanol to give a yellow solid. Since the solubility of the solvent used for purification is low and the purification is difficult, the yellow solid containing the intermediate (c) is used as it is in the following step. 43 201014862 Step 4: Polymerization of the compound of the palm compound (diporide) In a 4-port reactor equipped with a thermometer, a yellow solid containing the intermediate (c) synthesized in the previous step 3, 7〇8, 2_ propylene oxide ethyl succinic acid 4. 6g (21. 3mmol), 4-(dimethylamino)pyridinium · 26g (2. lmmol) dissolved in 2〇〇ml of N, N-dimethyl Base amine (hereinafter referred to as "DMF"). 4. lg (21 4 μ〇1) of ethyl ethyl(3-dimethylaminopropyl)carbonium diimine hydrochloride (wsc) was added to the solution at room temperature. Thereafter, the reaction was carried out for 18 hours at room temperature. After the completion of the reaction, the reaction solution was poured into water and extracted twice with 2 ml of ethyl acetate. The aqueous layer was removed by a liquid separation operation, and the obtained ethyl acetate layer was dried over anhydrous magnesium sulfate and filtered to remove magnesium sulfate. The ethyl acetate layer was concentrated on a rotary evaporator to give a pale yellow oil. The product was purified to give a pale yellow solid (yield: n-hexane: THF~5:5). The structure was identified by lH_NMR. (1H NMR data of the polymerizable compound (dipor)) ^-NMRCBOOMHz, CDCh, TMS, 5 ppm): 8.71 (s, 1H) ^ 8-69 (s, lH), 8.68 (s, lH), 8.68(s,lH), 8.48-8.47(m, 2H), 8.18(d, 2H, J = 8.5Hz) ^ 8. 12-8. 07(m, 4H), 7*96'7.92(m, 4H > 7. 24(dd, 2H, J = 1.5Hz, J = 8. 5Hz) ^ 6-44(d(i, 2H, J = l. 3Hz, J = 17.3Hz) ' 6. 14(dd , 2H, 5Hz, 17.3Hz), 5.86(dd, 2H, J = l.3Hz, J = 10.5Hz), 5.53(s,1H), 5.47(q,1H, J = 5. 0Hz, J = L〇· 5Hz), 5.12(t, 1H, J = 5.0Hz), 4.73(d, 1H, J = 5.〇Hz), 4.39(s, 8H), 4· 15-4· 14(m , 2H), 4. ll (d, 2H, J = 5. 0Hz), 3. 92(s, 6H), 44 201014862 3.02(t, 4H, J=7.〇H,).2.83(t5 4Rj J = ? 〇 Hz) (Example 2) Polymerization of the palm compound (i_2)

ooc- 化合物(I一 2)Ooc- compound (I-2)

JOOCHa 聚合性對掌性化合物(H)的合成的步驟 4爷丙稀酿-已基+基氧)安息香酸(日本席貝爾河^用 公司製造)取K 2-丙締醯氧乙基琥拍酸以外納 掌性化合物(1-1)的合成法進行同樣的反應以及後處對 由矽膠管柱層析法(正己烷:THF = 5 : 5)精製得到的反應、: 物,以得到聚合性對掌性化合物(〗_2)。構 b昆。 鑑定。 ^以Η侧 (聚合性對掌性化合物(卜2)的lH_NMR資料) H-NMR(400MHz, CDCls, TMS, <5 ppm) : 8. 68(m, 4H) ' ^ 8.48(s, 2H)、8. 16-8.08(m,10H)、7.92(t,4H,J = 9.〇Hz)、 7.33(d,2H,J = 8.2Hz)、6.97(d,4H,J = 8.2Hz)、6.38(d, 2H,J = 17.4Hz)、6.13(dd,2H,J = 10.1Hz,J = 17.4Hz)、 5.81(d,2H,J = 10.1Hz)、5.51(s,lH)、5.45(dd,1H, J = 5.0Hz, J = 10. 5Hz) ' 5. 09(t, 1H, J = 5. 0Hz) ' 4. 71 (d, 1H, J = 4. 6Hz)、4.19-3. 99(m,12H)、3.77(s, 6H)、1.83-1.45(m, 16H)。 (實施例3)聚合性對掌性化合物(1-3)的合成 【化20】 45 201014862JOOCHa Polymerization Steps for the Synthesis of Palm Compound (H) 4 propylene-glycine-based ketone-based benzoic acid (manufactured by Shibahe Corporation, Japan) Take K 2-propyl sulfonate The same reaction is carried out by the synthesis method of the acid-free compound (1-1), and the reaction obtained by purifying the column chromatography (n-hexane: THF = 5: 5) is carried out to obtain a polymerization. Sexual versus palm compound (〗 〖). Construction b Kun. Identification. ^ΗΗ(1H_NMR data of polymerizable versus palmitic compound) (H-NMR (400MHz, CDCls, TMS, < 5 ppm) : 8. 68(m, 4H) ' ^ 8.48(s, 2H ), 8. 16-8.08 (m, 10H), 7.92 (t, 4H, J = 9.〇Hz), 7.33 (d, 2H, J = 8.2Hz), 6.97 (d, 4H, J = 8.2Hz) , 6.38 (d, 2H, J = 17.4 Hz), 6.13 (dd, 2H, J = 10.1 Hz, J = 17.4 Hz), 5.81 (d, 2H, J = 10.1 Hz), 5.51 (s, lH), 5.45 (dd,1H, J = 5.0Hz, J = 10. 5Hz) ' 5. 09(t, 1H, J = 5. 0Hz) ' 4. 71 (d, 1H, J = 4. 6Hz), 4.19-3 99 (m, 12H), 3.77 (s, 6H), 1.83-1.45 (m, 16H). (Example 3) Synthesis of polymerizable palmitic compound (1-3) [Chem. 20] 45 201014862

化合物(I — 3) 步驟1 :中間體(d)的合成 【化21】Compound (I-3) Step 1: Synthesis of intermediate (d) [Chem. 21]

聚合性對掌性化合物(1-1)的合成之中的步驟3,除了 使用乙基香草精(3-乙氧-4-羥苯甲醛)取代中間體(3)以 外’與聚合性對掌性化合物(H )的合成法同樣地進行反 應’得到含有中間體(d)的黃色固體。得到之含有中間體(d) 的黃色固體’不精製而直接使用於之後的步驟。 步驟2 :聚合性對掌性化合物(〗_3 )的合成 在備有溫度計的4 口反應器、氮氣流中,將之前步驟 1得到含中間體(d)的黃色固體3.〇g、2_丙烯醯氧乙基琥珀 酸 2. 0g(9. 25mni〇l)、4-(二甲基胺基)吡啶 〇. 〇5g(〇 4mm〇1)Step 3 of the polymerization of the palmitic compound (1-1), except that ethyl vanillin (3-ethoxyxo-4-hydroxybenzaldehyde) is substituted for the intermediate (3) The synthesis of the compound (H) was carried out in the same manner to give a yellow solid containing the intermediate (d). The obtained yellow solid containing the intermediate (d) was used in the next step without purification. Step 2: Synthesis of polymerizable palmitic compound (〖_3) In a 4-port reactor equipped with a thermometer, a nitrogen stream, the previous step 1 was obtained to obtain a yellow solid containing the intermediate (d) 3. 〇g, 2_ Propylene oxime ethyl succinic acid 2. 0g (9. 25mni〇l), 4-(dimethylamino)pyridinium. 〇5g (〇4mm〇1)

溶解於200ml的DMF。在室温下加入卜乙基_3_(3二甲基 胺基丙基)碳醯二亞胺鹽酸鹽(wsc)41g(2l 4mm〇i)於此溶 液中之後’在至溫下進行j 8個小時反應。反應終了後將 反應液投入水中,且利用乙酸 藉由分液操作去除水層,且利 酸乙酯層之後,進行過濾以去 乙酯200ml進行2次抽出。 用無水硫酸鎂乾燥得到的乙 除硫酸鎂。以旋轉蒸發器濃 46 201014862 縮乙酸乙酯層以得到淡黃色油狀物。藉由矽膠管柱層析法 (氣仿:乙酸乙醋=95 : 5)精製得到的油狀物,成為淡黃色固 體,以得到0 72g的聚合性對掌性化合物(1-3) 〇構造是以 j-NMR鑑定。 (聚合性對掌性化合物(1-3)的1H-NMR資料) 1H-NMR(400MHz, CDCls, TMS, 5 ppm) : 8. 66(d, 2H J = 6. 0)、8. 59-8. 55(m,2H)、8. 16-8· 05(m, 4H)、7. 9〇(t 4H,J = 8. 0Hz)、7. 56(s,2H)、7. 30-7· 2 0(m,2H)、7. 12(m, ,2H)、6. 42(d,2H,J = 17· 4Hz)、6. 12(dd,2H,J = l〇. iHz, J = 17.4Hz)、5.84(d,2H,J = 10.1Hz)、5.52(s,lH)、5.46(dd, 1H, J = 5.5Hz, J = l〇. 5Hz) ' 5. l〇(t, 1H, J = 5. 5Hz) > 4. 71 (d, 1H,J = 4.2Hz)、4.40-4.05(m,16H)、3.00-2.75(m,8H)、 1. 42("t,6H,J = 6. 9Hz)。 (實施例4)聚合性對掌性化合物(I_4)的合成 【化22】Dissolved in 200 ml of DMF. After adding diethyl _3_(3 dimethylaminopropyl) carbodiimide hydrochloride (wsc) 41g (2l 4mm〇i) in this solution at room temperature, it is carried out at room temperature for 8 hours. reaction. After the completion of the reaction, the reaction mixture was poured into water, and the aqueous layer was removed by a liquid separation operation using acetic acid, and then the ethyl acetate layer was filtered, and then ethyl acetate (200 ml) was taken and extracted twice. The obtained ethyl acetate was dried over anhydrous magnesium sulfate. The ethyl acetate layer was evaporated to give a pale yellow oil. The obtained oil was purified by a silica gel column chromatography (methanol: ethyl acetate = 95: 5) to give a pale-yellow solid to give a polymer. It was identified by j-NMR. (1H-NMR data of the polymerizable compound (1-3)) 1H-NMR (400 MHz, CDCls, TMS, 5 ppm): 8. 66 (d, 2H J = 6. 0), 8. 59- 8. 55(m, 2H), 8. 16-8· 05(m, 4H), 7. 9〇 (t 4H, J = 8. 0Hz), 7. 56(s, 2H), 7. 30- 7· 2 0 (m, 2H), 7. 12 (m, , 2H), 6. 42 (d, 2H, J = 17· 4Hz), 6. 12 (dd, 2H, J = l〇. iHz, J = 17.4 Hz), 5.84 (d, 2H, J = 10.1 Hz), 5.52 (s, lH), 5.46 (dd, 1H, J = 5.5 Hz, J = l 〇. 5 Hz) ' 5. l〇(t , 1H, J = 5. 5Hz) > 4. 71 (d, 1H, J = 4.2Hz), 4.40-4.05(m, 16H), 3.00-2.75(m, 8H), 1. 42("t , 6H, J = 6. 9Hz). (Example 4) Synthesis of polymerizable palmitic compound (I_4) [Chem. 22]

在備有溫度計、滴下漏斗的4 口反應器、氮氣流中, 將4-(6-丙烯醯-己基―卜基氧)安息香酸(日本席貝爾河古 納公司製造)2. 7g(9. 24mmol)、甲烷磺醯氣1. ig(9. 6mm〇1) 洛解於5〇ml的THF。利用冰浴冷卻後以3〇分鐘滴下三 乙基胺1. 0g(9. 88mmol),滴下終了後,以相同的溫度進行 1小時反應。其次,加入上述得到之含中間體(d)的黃色固 47 201014862 體3.0g以及4-(二甲基胺基)吡啶0.12g(9 88mm〇1)於反應 液中。其次’在冰浴下,以30分鐘滴下三乙基胺 1.0g(9.88mmol),滴下終了後,再於室溫進行4小時反應。 反應終了後,以1小時投入甲醇150ml於反應液中,再利 用過濾將析出的沈澱物回收,並且曱醇洗淨過遽物。使得 到的過濾物溶解於氣仿,藉由矽膠管柱層析法(氣仿:乙酸 乙醋=95: 5)精製,得到0.56g的黃色固體的聚合性對掌性 化合物(1-4)。構造是以1h-NMR鑑定。 (聚合性對掌性化合物(1-4)的1H-NMR資料) _ 1H-NMR(400MHz, CDCh, TMS, 5 ppm) : 8. 53(d, 2H,5克(9. 9g(9.) </ br> </ br> </ br> </ br> </ br> </ br> </ br> 24 mmol), methane sulfonium gas 1. ig (9. 6 mm 〇 1) Loose in 5 〇 ml of THF. After cooling with an ice bath, triethylamine 1.0 g (9.88 mmol) was added dropwise over 3 minutes, and after the completion of the dropwise addition, the reaction was carried out at the same temperature for 1 hour. Next, 3.0 g of the yellow solid 47 201014862 body containing the intermediate (d) obtained above and 0.12 g of 4-(dimethylamino)pyridine (9 88 mm 〇 1) were added to the reaction liquid. Next, 1.0 g (9.88 mmol) of triethylamine was added dropwise thereto under ice bath for 30 minutes, and after completion of the dropwise addition, the reaction was further carried out at room temperature for 4 hours. After the completion of the reaction, 150 ml of methanol was introduced into the reaction liquid over 1 hour, and the precipitate which precipitated was recovered by filtration, and the decyl alcohol was washed. The obtained filtrate was dissolved in a gas mixture, and purified by a rubber column chromatography (gas: ethyl acetate = 95: 5) to obtain a polymerizable palmitic compound (1-4) of 0.56 g of a yellow solid. . The structure was identified by 1 h-NMR. (1H-NMR data of the polymerizable compound (1-4)) _ 1H-NMR (400 MHz, CDCh, TMS, 5 ppm): 8. 53 (d, 2H,

J = 6.〇Hz)、8.49(d,2H,J = 2.8Hz)、8.02-7.94(m,8H)、 7.77(t,4H, J=9.2Hz)、7.46(s,2H)、7.21(d,2H J = 8. 2Hz)、7. 09(m,2H)、6. 82(d,4H,J = 8. 7Hz)、6. 4〇(d, 2H,J = n.4Hz)、6.12(dd,2H,J = 10.1Hz,J = l7.4Hz)、 5.83(d,2H,J = 1〇.ihz)、5.53(s,lH)、5.46(dd,1H j = 5.5Hz,J = 10. 5Hz)、5.10(t,1H,J = 5. 5Hz)、4. 72(d 1H j=4.6Hz) 、 4.20-4.〇6(m, 16H) 、 1·83-1.45(m, 22H) 。 ^ (實施例5)聚合性對掌性化合物(1-5)的合成 【化23】J = 6.〇Hz), 8.49(d,2H,J = 2.8Hz), 8.02-7.94(m,8H), 7.77(t,4H, J=9.2Hz), 7.46(s,2H), 7.21( d, 2H J = 8. 2 Hz), 7. 09 (m, 2H), 6. 82 (d, 4H, J = 8. 7 Hz), 6.4 〇 (d, 2H, J = n. 4 Hz), 6.12 (dd, 2H, J = 10.1 Hz, J = l7.4 Hz), 5.83 (d, 2H, J = 1 〇.ihz), 5.53 (s, lH), 5.46 (dd, 1H j = 5.5 Hz, J = 10. 5Hz), 5.10(t,1H,J = 5. 5Hz), 4.72(d 1H j=4.6Hz), 4.20-4.〇6(m, 16H), 1·83-1.45(m , 22H). ^ (Example 5) Synthesis of polymerizable palmitic compound (1-5) [Chem. 23]

步驟1 :中間體(e)的合成 【化24】 48 201014862Step 1: Synthesis of intermediate (e) [Chem. 24] 48 201014862

聚合性對掌性化合物(1-1)的合成之中的步驟3之 中,使用3-氟-4-羥基苯甲醛取代中間體(3),進行與聚人 性對掌性化合物(H)的合成法同樣的反應,以得到含中二 體(e)的黃色固體。此中間體(e)不精製而直接使用於以下 的步驟。 m 步驟2 .聚合性對掌性化合物(丨_ 5)的合成 聚合性對掌性化合物(1-3)的合成之中的步驟2之 中’使用之前的步驟1得到的含中間體(6)的黃色固體取代 含中間體(d)的黃色固體以外,進行與聚合性對掌性化合物 (1-3)的合成法同樣的反應及後處理,藉由矽膠管柱層析法 (氣仿:乙酸乙酯=95:5)精製得到的反應混合物,得到黃色 固體的聚合性對掌性化合物(1-5)。構造是以1H-NMR鑑定。 ^ (聚合性對掌性化合物(1-5)的1H-NMR資料) 1H-NMR(400MHz, CDCls, TMS, &lt;5 ppm) : 8. 68(d, 2H, J = 6.0Hz)、8.63(d, 2H,J = 2.3Hz)、8.15(d,2H, J = 8.2Hz)、 8.09(d,2H, J = 8.2Hz)、7.92(t,4H,J = 9.0Hz)、7.73(d, 2H, J = 10.6Hz) ' 7.56(d, 2H, J = 8.2Hz) ' 7.27(m, 2H) &gt; 6. 42(d, 2H, J = 17.4Hz) ' 6. 12(dd, 2H, J = l〇. 1Hz, J = 17.4Hz)、5.84(d, 2H,J = 10.1Hz)、5.52(s,lH)、5.45(dd, 1H, J = 5.2Hz, J = 10. 8Hz) ' 5. l〇(t, 1H, J = 5. 0Hz) ' 4. 71 (d, 1H, J = 4.6Hz)、4.37(s, 8H)、4. 10-4. 08(m, 4H)、 201014862 3·00-2.75(m, 8H)。 (實施例6)聚合性對掌性化合物(1_6)的合成 【化25】Among the steps 3 in the synthesis of the palmitic compound (1-1), 3-fluoro-4-hydroxybenzaldehyde is used in place of the intermediate (3), and the polytropic palm compound (H) is used. The same reaction was carried out by a synthetic method to obtain a yellow solid containing a dimer (e). This intermediate (e) was used in the next step without further purification. m Step 2. Polymerization of the compound of the palm compound (丨 5) Polymerization of the intermediate compound (6) obtained in the first step of the preparation of the palm compound (1-3) The yellow solid is replaced by a yellow solid containing the intermediate (d), and the same reaction and post-treatment as in the polymerization of the palmitic compound (1-3) are carried out by gel column chromatography (gas imitation). : ethyl acetate = 95:5) The obtained reaction mixture was purified to give a polymerizable compound (1-5) as a yellow solid. The structure was identified by 1H-NMR. ^ (1H-NMR data of the polymerizable compound (1-5)) 1H-NMR (400 MHz, CDCls, TMS, &lt; 5 ppm) : 8. 68 (d, 2H, J = 6.0 Hz), 8.63 (d, 2H, J = 2.3Hz), 8.15 (d, 2H, J = 8.2Hz), 8.09 (d, 2H, J = 8.2Hz), 7.92 (t, 4H, J = 9.0Hz), 7.73 (d , 2H, J = 10.6Hz) ' 7.56(d, 2H, J = 8.2Hz) ' 7.27(m, 2H) &gt; 6. 42(d, 2H, J = 17.4Hz) ' 6. 12(dd, 2H , J = l〇. 1Hz, J = 17.4Hz), 5.84(d, 2H, J = 10.1Hz), 5.52(s,lH), 5.45(dd, 1H, J = 5.2Hz, J = 10. 8Hz) ' 5. l〇(t, 1H, J = 5. 0Hz) ' 4. 71 (d, 1H, J = 4.6Hz), 4.37(s, 8H), 4. 10-4. 08(m, 4H) , 201014862 3·00-2.75 (m, 8H). (Example 6) Synthesis of polymerizable palmitic compound (1_6) [Chem. 25]

聚合性對掌性化合物(1-4)的合成之中,使用上述得到 的含中間體(e)的黃色固體取代含中間體(d)的黃色固體以 外,進行與聚合性對掌性化合物(1_4)的合成法同樣的反應 以及後處理’再藉由紗膝管柱層析法(氣仿:乙酸乙醋= 95.5) ^ 精製得到的反應混合物,以得到聚合性對掌性化合物 (1-6)。構造是以1H-NMR鑑定。 (聚合性對掌性化合物(I-6)的j-NMR資料) 1H-NMR(400MHz, CDCls, TMS, &lt;5 PPm) : 8. 68(d&gt; 2H, J=6·0Hz) 、 8.63(d, 2H, J=2.3Hz) 、 8.18~8·〇9(m 8H)、 7.93(t, 4H, J=9.2Hz) 、 7.78(d, 2H, J=l〇.5Hz) 、 7.62(d, 2H,J = 8. 2Hz)、7. 36(d,2H,J = 8. 2Hz)、6. 98(d,4H, Q J = 8.7Hz)、6.40(d,2H,J = 17.4Hz)、6.12(dd,2H J = 10 1Hz, J = 17.4Hz)、5.81(d,2H,J = 10.1Hz)、5.53(s,iH)、5.46(dd, 1H,J = 5.5,J = l〇.2Hz)、5.10(t,1H,J = 5.5Hz)、4.72(d, 1H,J = 4.6Hz)、4· 20-4.04(m,12H)、1. 83-1·45(m,16H)。 (實施例7)聚合性對掌性化合物(1-7)的合成 【化26】 50 201014862In the synthesis of the palmitic compound (1-4), the yellow solid containing the intermediate (e) obtained above is used in place of the yellow solid containing the intermediate (d), and the polymerizable palm compound is 1_4) Synthetic method The same reaction and post-treatment 'reduced the reaction mixture by the yarn knee column chromatography (gas: ethyl acetate = 95.5) ^ to obtain a polymerizable palmitic compound (1- 6). The structure was identified by 1H-NMR. (j-NMR data of the polymerizable compound (I-6)) 1H-NMR (400 MHz, CDCls, TMS, &lt; 5 PPm) : 8. 68 (d &gt; 2H, J = 6 · 0 Hz), 8.63 (d, 2H, J=2.3Hz), 8.18~8·〇9(m 8H), 7.93(t, 4H, J=9.2Hz), 7.78(d, 2H, J=l〇.5Hz), 7.62( d, 2H, J = 8. 2Hz), 7. 36(d, 2H, J = 8. 2Hz), 6. 98(d, 4H, QJ = 8.7Hz), 6.40(d, 2H, J = 17.4Hz ), 6.12 (dd, 2H J = 10 1Hz, J = 17.4Hz), 5.81 (d, 2H, J = 10.1Hz), 5.53(s, iH), 5.46 (dd, 1H, J = 5.5, J = l 〇.2 Hz), 5.10 (t, 1H, J = 5.5 Hz), 4.72 (d, 1H, J = 4.6 Hz), 4·20-4.04 (m, 12H), 1. 83-1·45 (m, 16H). (Example 7) Synthesis of polymerizable palmitic compound (1-7) [Chem. 26] 50 201014862

ch3 化合物(I 一 7) 步驟1 :中間體(f)的合成 【化27】Ch3 compound (I-7) Step 1: Synthesis of intermediate (f) [Chem. 27]

中間體⑴ 聚合性對掌性化合物(1-1)的合成之中,使用4-羥基 -3, 5-二甲基苯曱醛取代中間體(a)以外,進行與聚合性訝 掌性化合物(1-1)同樣的反應,以得到含中間體(f)的黃色 固體。此中間體(f)不精製而直接使用於以下的步驟。 步驟2 :聚合性對掌性化合物(1_7)的合成Intermediate (1) In the synthesis of the palmitic compound (1-1), 4-hydroxy-3,5-dimethylbenzaldehyde is used in place of the intermediate (a), and a polymerizable compound is synthesized. (1-1) The same reaction was carried out to obtain a yellow solid containing intermediate (f). This intermediate (f) was used in the next step without purification. Step 2: Synthesis of polymerizable palmitic compound (1_7)

聚合性對掌性化合物(I一4)的合成之中,使用上述得到 的含中間體(f)的黃色固體取代含中間體(d)的黃色固體以 卜/進行與聚合性對掌性化合物(1_4)的合成法同樣的反應 及後處理,藉由矽膠管柱層析法(氣仿:乙酸乙醋=95:5) 精製得到的反應混合物,得到聚合性對掌性化合物(卜乃。 構造是以1H-NMR鑑定。 (聚合性對掌性化合物(1_7)的ih_nmr資料) δ PPm) : 8. 70(d, 2H, 8·21-8.09(m, 8H) ' 4H) ' 6. 98(d, 4H, 51 1 H-NMR(400MHz, CDCh, TMS, J = 6.〇Hz)、8.64(d,2H,J = 2.7Hz) 7. 93(t,4H,J = 9. 2Hz)、7. 64(s’ 201014862 J = 8. 7Hz)&gt; 6. 40(d, 2H, J = 17. 4 Hz) &gt; 6. 12(dd, 2H, J = 10.1Hz, J = 17.4Hz)、5.81(d,2H, J = 1〇.ihz)、5.54(s, lH)、5.47(dd, Ifl,J = 5.2Hz,J = 10.5Hz)、5.11(t,1H,J = 5.0Hz)、4.73(d, 1H,J = 4.6Hz)、4.20-4. 〇4(m,12H)、2.26(s,12H)、 I 83-1.45(m, 16H)。 (螺旋扭轉力(HTP)的測定) 將ZEONOA薄膜(〇PTES公司製造,ZF16-100)的單面進 行電暈放電處理’其次在此面塗佈聚乙烯醇的5質量%水溶 液(可樂麗(Kuraray)公司製造,Poval Mp2〇3),再於1〇〇 c乾燥3分鐘後’利用毛布滾輪摩擦,形成配向膜以得到 基材。 將聚合性液晶化合物1 〇 〇部溶解於環戊酮15 3部,以 成為溶液。在此溶液添加光聚合起始劑(汽巴精化公司製 造:Irgacurel919)3.3部 '對掌化劑6.5部、界面活性劑 (使用1重量%的環戊酮溶液)117部’再將全體完全地溶 解而調製聚合性液晶組成物。 對掌化劑分別使用實施例1〜7所合成的聚合性對掌性 化合物(1-1)〜(1 — 7)。 聚合性液晶化合物,使用特願2008-92093號記載的方 法製造的化合物(下述式(LC)所述的化合物)。 界面活性劑使用清美化學(株)製造的KH-40。 【化28】 52 201014862In the synthesis of the palmitic compound (I-4), the yellow solid containing the intermediate (f) obtained above is substituted for the yellow solid containing the intermediate (d) to carry out the polymerization with the palmitic compound. (1_4) Synthetic method The same reaction and post-treatment were carried out, and the obtained reaction mixture was purified by silica gel column chromatography (gas: ethyl acetate = 95:5) to obtain a polymerizable palm compound (Bu Na. The structure was identified by 1H-NMR. (Polymerization of the ih_nmr data of the palm compound (1_7)) δ PPm) : 8. 70 (d, 2H, 8·21-8.09 (m, 8H) ' 4H) ' 6. 98(d, 4H, 51 1 H-NMR (400MHz, CDCh, TMS, J = 6.〇Hz), 8.64 (d, 2H, J = 2.7Hz) 7. 93(t,4H,J = 9. 2Hz ), 7. 64 (s' 201014862 J = 8. 7Hz) &gt; 6. 40(d, 2H, J = 17. 4 Hz) &gt; 6. 12(dd, 2H, J = 10.1Hz, J = 17.4 Hz), 5.81 (d, 2H, J = 1 〇.ihz), 5.54 (s, lH), 5.47 (dd, Ifl, J = 5.2 Hz, J = 10.5 Hz), 5.11 (t, 1H, J = 5.0) Hz), 4.73 (d, 1H, J = 4.6 Hz), 4.20-4. 〇4 (m, 12H), 2.26 (s, 12H), I 83-1.45 (m, 16H). (Helical torsion force (HTP) Determination) ZEONOA film (〇PTES) One side of the ZF16-100) was subjected to corona discharge treatment. Secondly, a 5 mass% aqueous solution of polyvinyl alcohol (manufactured by Kuraray Co., Ltd., Poval Mp2〇3) was applied thereto, and then 1 制造c After drying for 3 minutes, the film was rubbed with a felt roller to form an alignment film to obtain a substrate. The polymerizable liquid crystal compound 1 was dissolved in 15 parts of cyclopentanone to form a solution. A photopolymerization initiator was added to the solution. (Manufactured by Ciba Specialty Chemicals Co., Ltd.: Irgacurel 919) 3.3 parts of 6.5 parts of palmizing agent and 117 parts of surfactant (using 1% by weight of cyclopentanone solution), and completely dissolving the whole to prepare a polymerizable liquid crystal composition The polymerizable palmitic compound (1-1) to (1-7) synthesized in Examples 1 to 7 were used for the palmizing agent. The polymerizable liquid crystal compound was produced by the method described in Japanese Patent Application No. 2008-92093. A compound (a compound of the following formula (LC)). The surfactant is KH-40 manufactured by Seimi Chemical Co., Ltd. [Chem. 28] 52 201014862

(LC) 。其-人,利用孔禮〇· 45㈣的聚四氣乙婦製針筒過滤 器,過濾、上述得到的聚合性液晶組成物成為試料。將得到 的試料塗佈於上述基材的配向膜上,再於乾燥2分 鐘,以形成塗佈膜。 刀 其次,以水銀燈照射相當於2000mJ/cm2 η 到的塗佈膜上,㈣成厚度約5公分㈣⑽高分 膜。 λ為利用分光光度計(大塚電子公司製造、瞬間多測 光系統MCPD-3000)測定膽固醇高分子硬化膜的選擇反射頻 帶的中心值λ (m),並且以下列式子求得螺旋扭轉力ΗΤρ。 【數1] 式:ΗΤΡ = η/ (λ X c) 上述式子之中’ C為相對於聚合性液晶組成物的對掌 化劑的濃度(質量部/100),η為聚合性液晶化合物的平均 折射率。結果整理顯示於表1。 表1 聚合性對掌性化合物 HTP(//zm) 1-1 32.0 1~2 46.5 1-3 32.2 1-4 47· 0 1-5 25.5 1-6 29.6 1-7 42.7 的聚合性對掌性化合物 由表1可得知,實施例1~7 53 201014862 (1-1)〜(1-7)具有高螺旋扭轉力(HTP)。 【圖式簡單說明】 無0 【主要元件符號說明】 無。(LC). In the same manner, the polymerized liquid crystal composition obtained by the above method was used as a sample by using a polytetrafluoroethylene syringe filter of Kong Lizhen 45(4). The obtained sample was applied onto the alignment film of the above substrate, and dried for 2 minutes to form a coating film. Knife Next, a coating film corresponding to 2000 mJ/cm2 η is irradiated with a mercury lamp, and (4) a film having a thickness of about 5 cm (four) (10) is formed. λ is a measurement of the center value λ (m) of the selective reflection band of the cholesterol polymer cured film by a spectrophotometer (manufactured by Otsuka Electronics Co., Ltd., instantaneous multi-photometry system MCPD-3000), and the helical torsion force ΗΤρ is obtained by the following equation. [Expression 1] Formula: ΗΤΡ = η / (λ X c) In the above formula, 'C is the concentration of the palmizing agent relative to the polymerizable liquid crystal composition (mass portion / 100), and η is a polymerizable liquid crystal compound The average refractive index. The results are shown in Table 1. Table 1 Polymeric versus palm compound HTP (//zm) 1-1 32.0 1~2 46.5 1-3 32.2 1-4 47· 0 1-5 25.5 1-6 29.6 1-7 42.7 Polymerization versus palm The compounds are known from Table 1. Examples 1 to 7 53 201014862 (1-1) to (1-7) have high helical twisting force (HTP). [Simple description of the diagram] No 0 [Description of main component symbols] None.

5454

Claims (1)

201014862 七、申請專利範圍: 1 · 一種聚合性對掌性化合物,以下式(I)表示: 【化1】 Z1-Y1- G 十 Υ2-Α1)^Υ3-Α2-^1 ^-ΑΒ-ΥΑ-Χ-Υδ-Αβ^^-Αδ-Υδ 十 A6-Y7\G2-Y8-Z2 (D [式中’ Y1-Y8各自獨立表示化學性單結合-0-、-s-、 〇 _ C ( - 0 ) -、- C (=〇 ) - 〇 -、- 〇 - C ( = 0 ) - 0 -、- N R1 - C (= 0 )-、 -C(=0)-NR1---0-C( = 0)-NR1---NR1-C(=0)-0---NR1-C(=0)- NR1-、-0-NR1-、或者—Nf-o-,在此,R1表示氫原子或碳數 1〜6的燒基, G1以及G2各自獨立表示可以具有取代基的碳數卜別 的2價脂肪族基’在該脂肪族基中,可以插入_〇_、 s 、 -〇-C(=0)- 、 -c(=〇)-〇- 、 _〇_c(=〇)_〇_ 、 _nr2_c(=〇)_ 、 -C( = 〇)-NR2-、或者 _c( = 〇)_,但是 _〇 以及 _s 各自鄰 接2以上而插入的情況除外,在此,R2表示氫原子或碳數 、1〜6的烧基, Z1以及Z2各自獨立表示可以被鹵素原子取代的碳數 2〜10的烯基, Q-Q4各自獨立表示氫原子、或者可以具有取代基的碳 數1〜6的烷基, A1〜A6各自獨立表示碳數63〇的2價芳香族A, X表示下述(X-i)〜(X_vi)的任一者的基團, 【化2】 55 201014862201014862 VII. Patent application scope: 1 · A polymeric palm-like compound, the following formula (I) means: [Chemical 1] Z1-Y1- G Υ2-Υ1)^Υ3-Α2-^1 ^-ΑΒ-ΥΑ -Χ-Υδ-Αβ^^-Αδ-Υδ Ten A6-Y7\G2-Y8-Z2 (D [wherein Y1-Y8 each independently represents a chemical single bond-0-, -s-, 〇_C ( - 0 ) -, - C (=〇) - 〇-, - 〇- C ( = 0 ) - 0 -, - N R1 - C (= 0 )-, -C(=0)-NR1---0 -C( = 0)-NR1---NR1-C(=0)-0---NR1-C(=0)- NR1-, -0-NR1-, or -Nf-o-, here, R1 represents a hydrogen atom or a carbon group having 1 to 6 carbon atoms, and G1 and G2 each independently represent a carbon number which may have a substituent, and a divalent aliphatic group, in which an aliphatic group can be inserted into _〇_, s , -〇-C(=0)-, -c(=〇)-〇-, _〇_c(=〇)_〇_, _nr2_c(=〇)_, -C( = 〇)-NR2-, Or _c( = 〇)_, except that _〇 and _s are inserted adjacent to each other by 2 or more. Here, R2 represents a hydrogen atom or a carbon number, and a burning group of 1 to 6, and Z1 and Z2 each independently represent Alkenyl group having 2 to 10 carbon atoms substituted by a halogen atom, Q-Q4 each independently a hydrogen atom or an alkyl group having 1 to 6 carbon atoms which may have a substituent, and each of A1 to A6 independently represents a divalent aromatic A having a carbon number of 63 Å, and X represents any of the following (Xi) to (X_vi). Group, [Chem. 2] 55 201014862 (式中,*表示結合手,Li〜L4各自獨立表示碳數卜4的 烧基、碳數1〜4的烧氧基、鹵素原子、-C00R3、-0C0R3、 -0C00R3、-C0NHR3、或NHC0R3,在此,R3表示氫原子或碳數 1 ~ 6的烧基, a以及b各自獨立為〇或1)。 2. 如申請專利範圍第1項所述之聚合性對掌性化合 物,其中A1〜A6各自獨立表示可以具有取代基的伸苯基、 可以具有取代基的聯伸苯基、或可以具有取代基的伸萘基。 3. 如申請專利範圍第1項所述之聚合性對掌性化合 物’其中上述式(I)之中,Z1以及Z2各自獨立為CH2 = CH-、 CH2=C(CH3)-、CH2 = C(C1)-、CH2 = CH-CH2-、CH2=C(CH3)-CH2-、 CH2 = C(CH3)-CH2CH2-、(CH3)2C=CH-CH2-、ch3-ch=ch-、或 CH3-CH = CH—CH2-。 201014862 4.如申請專利範圍第1項所述之聚合性對掌性化合 物,上述式(I)之中,X為下述(X-iii) 【化3】(wherein * represents a bonding hand, and Li to L4 each independently represent a carbon group of carbon number 4, an alkoxy group having a carbon number of 1 to 4, a halogen atom, -C00R3, -0C0R3, -0C00R3, -C0NHR3, or NHC0R3. Here, R3 represents a hydrogen atom or a burnt group having 1 to 6 carbon atoms, and a and b are each independently 〇 or 1). 2. The polymerizable palmitic compound according to claim 1, wherein A1 to A6 each independently represent a phenyl group which may have a substituent, a phenyl group which may have a substituent, or may have a substituent Naphthyl. 3. The polymerizable palmitic compound as described in claim 1 wherein Z1 and Z2 are each independently CH2 = CH-, CH2=C(CH3)-, CH2 = C (C1)-, CH2 = CH-CH2-, CH2=C(CH3)-CH2-, CH2 = C(CH3)-CH2CH2-, (CH3)2C=CH-CH2-, ch3-ch=ch-, or CH3-CH = CH-CH2-. 201014862 4. The polymerizable palmitic compound according to claim 1, wherein X is the following (X-iii) in the above formula (I). CX-iii) 式中,*表示結合手。 _ 5.如申請專利範圍第1項所述之聚合性對掌性化合 物,上述式(I)之中,Y1〜Y8各自獨立為-C( = 0)-0-、 -0-c(=o)_ 、或-〇-, G1以及G2各自獨立為可以插入0-、-0( = 0)-0-、 _0—C( = 0)—、-C( = 0)-的-(CH2)6-或-(CH2)4-, Z1以及 Z2各自獨立為 CH2=CH-、CH2 = C(CH3)-或 CH2 = C(C1)-, 八146各自獨立表示下述(^-〇、(人-;^)或(人-丨^)所CX-iii) where * means the combined hand. 5. The polymerizable palmitic compound according to claim 1, wherein Y1 to Y8 are each independently -C(=0)-0-, -0-c(= o) _, or -〇-, G1 and G2 are each independently - can insert 0-, -0( = 0)-0-, _0-C( = 0)-, -C( = 0)--(CH2 6- or -(CH2)4-, Z1 and Z2 are each independently CH2=CH-, CH2=C(CH3)- or CH2=C(C1)-, and 146 each independently represents the following (^-〇, (person-;^) or (person-丨^) 【化4】 57 201014862[化4] 57 201014862 (A-i)(A-i) (A-ii)(A-ii) (A-iii) 上述式子中,氺表示結合手,X^Xu各自獨立表示氫原 子、齒素原子、可以具有取代基的碳數1〜1〇的烷基、氣基、 硝基、OR 、 -0-C(=0)-R4 、 -C(=〇)-〇R4 、 -〇~c(=〇)-〇R4 、 -NR5-c(=〇)-r、—c(=0)一N(r)r、或 _〇—c(=〇)_n(r4)r5, 在此,R、R各自獨立表示氫原子,或可以具有取代 基的碳數ho的⑥基,t ^及/或R5為㈣m在該 烧基中’可以插入♦、一s_、+c(=〇)_“c(令〇_、 、-nr6-c(=0)_、_c(„6_、_nr6_、或者 -C㈣)-,但是,♦以及_s_各自鄰接2以上而插人的情況 除外,在此,R1表示氫原子或碳數^的烷基。 58 1 .如申請專利範圍第1項所述之聚:性對掌性化合 物’上述式⑴之中,Υ1〜Υ8各自獨立為哥〇)_〇_、 201014862 -0-C(=0)-、或-〇-, G1 以及 G2 各自獨立為 _((:112)6_或_((:112)4 一, Z1以及Z2各自獨立為、cH2=CH_、或ch2=C(CH3), A卜A6各自獨立表示下述(Α_〇所示的基團, 【化5】(A-iii) In the above formula, 氺 represents a bonding hand, and X^Xu each independently represents a hydrogen atom, a dentate atom, an alkyl group having a carbon number of 1 to 1 可以 which may have a substituent, a gas group, a nitro group, and an OR group. , -0-C(=0)-R4, -C(=〇)-〇R4, -〇~c(=〇)-〇R4, -NR5-c(=〇)-r, -c(=0 ) N(r)r, or _〇-c(=〇)_n(r4)r5, wherein R and R each independently represent a hydrogen atom, or a 6-group of carbon number ho which may have a substituent, t ^ And / or R5 is (four) m in the burning base 'can be inserted ♦, a s_, +c (= 〇) _ "c (rang _,, -nr6-c (=0) _, _c („6_, _nr6_ Or -C(4))-, except that ♦ and _s_ are each adjacent to 2 or more and are inserted, except here, R1 represents a hydrogen atom or an alkyl group having a carbon number of 2. In the patent application, item 1 The aggregation: the palm-to-palm compound [in the above formula (1), Υ1 to Υ8 are each independently 〇 〇 、, 201014862 -0-C (=0)-, or -〇-, G1 and G2 Independently _((:112)6_ or _((:112)4 one, Z1 and Z2 are each independently, cH2=CH_, or ch2=C(CH3), Ab A6 each independently represents the following (Α_ Base shown Mission, [Chemical 5] 上述式子中,*表示結合手,Χι〜Κ各自獨立表示氫原 子、i素原子、可以具有取代基的碳數11()的烷基、氰基、 硝基、-OR4、-〇-C〇〇)-R4、_c(=〇)_〇r4、_〇 c( = 〇)_〇r4、 -NR5-C(=〇)-i^、_C(; = 〇)_n(R4)r5、4_〇_c(=〇)_n(r4)r5,r4' R各自獨立表示氳原子,或可以具有取代基的碳數【IQ的 烷基,當R4及/或R5為烷基的情況,在該烷基中,可以插 入 _〇—、、-0-CO0)-、-C( = 〇)-〇-、_0_c(=0)_0_、 % -NR6-C( = 0)-、一 c( = 〇)一NR6_、_nr6_、或者 _c( = 〇)_,但是, -〇-以及-S-各自鄰接2以上而插入的情況除外,在此,R6 表示氫原子或碳數的烷基。 7·如申請專利範圍第1項所述之聚合性對掌性化合 物,上述式(I)之中,Y1〜Y8各自獨立為一c(=〇)_〇_、 -〇-C(=〇)-、或_〇_ , G!以及G2各自獨立為- (CH2)6-或-(CH2)4-, Z1以及Z2各自獨立為、CH2=CH-, 59 201014862 Qi~Q4各自獨立表示氫原子或甲基, A1 A6各自獨立表示下述(A_i)所示的基團 【化6】In the above formula, * represents a bonding hand, and Χι~Κ each independently represents a hydrogen atom, an i atom, an alkyl group having a carbon number of 11 (), a cyano group, a nitro group, a -OR4, a -C-C group which may have a substituent. 〇〇)-R4, _c(=〇)_〇r4, _〇c( = 〇)_〇r4, -NR5-C(=〇)-i^, _C(; = 〇)_n(R4)r5, 4_〇_c(=〇)_n(r4)r5, r4' R each independently represents a halogen atom, or a carbon number which may have a substituent [IQ alkyl group, when R4 and/or R5 are an alkyl group, In the alkyl group, _〇-, -0-CO0)-, -C(= 〇)-〇-, _0_c(=0)_0_, %-NR6-C(=0)-, a c can be inserted. ( = 〇) - NR6_, _nr6_, or _c( = 〇)_, except that -〇- and -S- are adjacent to each other by 2 or more, where R6 represents a hydrogen atom or a carbon number alkyl group. . 7. The polymerizable palmitic compound according to claim 1, wherein Y1 to Y8 are each independently a c(=〇)_〇_, -〇-C(=〇 )-, or _〇_, G! and G2 are each independently - (CH2)6- or -(CH2)4-, Z1 and Z2 are each independently, CH2=CH-, 59 201014862 Qi~Q4 each independently represents hydrogen Atom or methyl group, A1 A6 each independently represents a group represented by the following (A_i) [Chemical 6] 乂3 X4 * (A-i) 上述式子中,*表示結合手,Χι〜Χ4各自獨立表示氫原 子、画素原子、可以具有取代基的碳數卜10的烷基、氰基、 硝基、⑽4、—0-C(=0)-R4 _:-C( = 0)-0R4,R4 表示氫原子,或 可以.美有取代基的碳數烧基當R4為烷基y績況, 在該烷基中,可以插入_〇_、_s_、—〇_c(=〇)_、^(4) 0一 或C( 0)但是,以及-S-各自鄰接2以上而插入的情 況除外。 δ'.,種聚合性液晶组釋,含有申請專利範κ j項 所述之聚合性對掌性化合物以及聚合性液晶化合物。 9_ 一種液晶性高分子,係將申請專利範圍第8頊所述 之聚合性液晶組成物聚合而得。 10.—種光學非等向體,係由申請專利範圍第9頊所述 之液晶性高分子作為構成材料。 60 201014862 - 四、指定代表圖: (一) 本案指定代表圖為:無。 (二) 本代表圖之元件符號簡單說明:無。 五、 本案若有化學式時,請揭示最能顯示發明特徵的化學式: 【化1】 工. ❹ (I) 六、 發明說明: 【發明所屬之技術領域】 本發明有關於具有高螺旋扭轉力的新穎聚合性對掌性 (chiral)化合物、含有該聚合性對掌性化合物的聚合性液 晶組成物、聚合該聚合性液晶組成物而得到液晶性高分子 以及以該液晶性高分子作為構成材料的光學非等向體。 .【先前技術】 具有膽固醇規則性的樹脂層(以下,也可稱為「膽固醇 樹脂層」)具有反射與膽固醇規則性的螺旋旋轉方向一致的 旋轉方向的圓偏光的特性(以下,此特性也稱為「選擇反射 特性」)。 表現此選擇反射特性的波長頻帶是由膽固醇的規則性 的周期決定。藉由使膽固醇規則性的周期分佈寬度變廣,乂3 X4 * (Ai) In the above formula, * represents a bonding hand, and Χι~Χ4 each independently represents a hydrogen atom, a pixel atom, an alkyl group having a carbon number of 10, a cyano group, a nitro group, and a (10) 4 group. —0-C(=0)-R4 _:-C( = 0)-0R4, R4 represents a hydrogen atom, or may be a substituted carbon number group. When R4 is an alkyl group, the alkane In the base, _〇_, _s_, -〇_c(=〇)_, ^(4) 0 or C(0) may be inserted, except that -S- is inserted adjacent to each other by 2 or more. δ'. A polymerizable liquid crystal group release containing the polymerizable palmitic compound and the polymerizable liquid crystal compound described in the patent application. 9_ A liquid crystalline polymer obtained by polymerizing a polymerizable liquid crystal composition as described in claim 8 of the patent application. 10. An optical anisotropic body which is a constituent material of the liquid crystalline polymer described in claim 9 of the patent application. 60 201014862 - IV. Designated representative map: (1) The representative representative of the case is: None. (2) A brief description of the symbol of the representative figure: None. 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: [Chemical 1] Work. ❹ (I) VI. Description of the invention: [Technical field of the invention] The present invention relates to a high helical torsion force A novel polymerizable chiral compound, a polymerizable liquid crystal composition containing the polymerizable palmitic compound, a polymerizable liquid crystal composition obtained by polymerizing the polymerizable liquid crystal composition, and a liquid crystal polymer as a constituent material. Optical anisotropic body. [Prior Art] A resin layer having a regularity of cholesterol (hereinafter also referred to as "cholesterol resin layer") has a characteristic of reflecting circularly polarized light in a rotating direction in accordance with a regular spiral rotation direction of cholesterol (hereinafter, this characteristic is also This is called "selective reflection characteristics"). The wavelength band exhibiting this selective reflection characteristic is determined by the regularity period of cholesterol. By broadening the regularity of the periodic distribution of cholesterol,
TW098132460A 2008-10-01 2009-09-25 Polymerizable palmitic compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical anisotropic body TWI450902B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008256855 2008-10-01

Publications (2)

Publication Number Publication Date
TW201014862A true TW201014862A (en) 2010-04-16
TWI450902B TWI450902B (en) 2014-09-01

Family

ID=42073362

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098132460A TWI450902B (en) 2008-10-01 2009-09-25 Polymerizable palmitic compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical anisotropic body

Country Status (7)

Country Link
US (1) US8603357B2 (en)
EP (1) EP2332942B1 (en)
JP (1) JP5522047B2 (en)
KR (1) KR101298371B1 (en)
CN (1) CN102171216B (en)
TW (1) TWI450902B (en)
WO (1) WO2010038591A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8287969B2 (en) 2010-10-06 2012-10-16 Industrial Technology Research Institute Isosorbide derivatives and liquid crystal displays comprising the same

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102791749B (en) * 2010-03-31 2016-03-16 日本瑞翁株式会社 Polymerizable chiral compound, polymerizable liquid crystal compound, liquid crystal liquid crystal property polymer and optically anisotropic body
JP5621584B2 (en) * 2010-12-27 2014-11-12 日本ゼオン株式会社 Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystalline polymer and optical anisotropic body
CN102660299B (en) * 2012-04-28 2015-02-04 深圳市华星光电技术有限公司 Liquid crystal medium mixture and liquid crystal display using same
CN102786936B (en) * 2012-05-09 2015-03-25 深圳市华星光电技术有限公司 Liquid crystal medium composition
US9441164B2 (en) * 2013-07-31 2016-09-13 Semiconductor Energy Laboratory Co., Ltd. Isosorbide derivative, liquid crystal composition, liquid crystal element, and liquid crystal display device
KR101628288B1 (en) 2013-09-30 2016-06-08 주식회사 엘지화학 Composition for manufacturing optical elements with negative optical dispersion and optically anisotropic body manufactured therefrom
CN108774293B (en) * 2013-10-31 2021-06-04 日本瑞翁株式会社 Compound, method for producing polymerizable compound, and hydrazine compound
WO2015132820A1 (en) * 2014-03-06 2015-09-11 株式会社有沢製作所 Optical element
EP3287462A1 (en) 2016-08-25 2018-02-28 Nitto Denko Corporation Isosorbide derivatives to treat bacterial biofilms
JP2022001901A (en) * 2020-06-19 2022-01-06 住友化学株式会社 Polarizer and method for manufacturing the same

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6270406A (en) 1985-09-24 1987-03-31 Fuji Photo Film Co Ltd Preparation of orientated film
JPH0815754B2 (en) 1987-07-27 1996-02-21 マツダ株式会社 Method and apparatus for manufacturing plastic hollow molded article
JPH0193287A (en) 1987-10-03 1989-04-12 Fuji Photo Film Co Ltd Simultaneous circuit for line sequential color difference signal
TW289095B (en) 1993-01-11 1996-10-21
WO1996002016A2 (en) 1994-07-12 1996-01-25 Philips Electronics N.V. Illumination system, linear polarizer for such an illumination system and a display device comprising such an illumination system
US5593617A (en) 1994-09-12 1997-01-14 Hoffmann-Laroche Inc. Photochemically polymerizable liquid crystals
GB2296807A (en) 1994-12-29 1996-07-10 Sharp Kk Illumination system
DE19520704A1 (en) 1995-06-09 1996-12-12 Basf Ag Polymerizable chiral compounds and their use
DE19520660A1 (en) 1995-06-09 1996-12-12 Basf Ag Polymerizable chiral compounds and their use
KR100217716B1 (en) 1996-04-25 1999-09-01 윤종용 Apparatus for fabricating an optical fiber coated with metal and method therefor
TW353145B (en) 1996-08-21 1999-02-21 Koninkl Philips Electronics Nv Method and device for manufacturing a broadband cholesteric polarizer
JP3931995B2 (en) 1996-11-19 2007-06-20 大日本インキ化学工業株式会社 Alkenylazines
CN1199938C (en) * 1996-08-22 2005-05-04 大日本油墨化学工业株式会社 Azine compound, process for preparation thereof, nematic liquid crystal composition and use in liquid crystal display system
JPH1171338A (en) * 1997-06-23 1999-03-16 Dainippon Ink & Chem Inc Tricyclic azine
JPH11100575A (en) 1997-07-31 1999-04-13 Asahi Glass Co Ltd Liquid crystal composition and high-molecular liquid crystal prepared by polymerizing the same
US6180028B1 (en) 1997-07-31 2001-01-30 Asahi Glass Company Ltd. Liquid-crystal composition and polymeric liquid crystal obtained by polymerizing the same
DE19843724A1 (en) 1997-10-08 1999-04-15 Basf Ag Chiral compound used as polymerizable, high-twisting-power dopant for the production of cholesteric networks
JP3948799B2 (en) 1997-10-27 2007-07-25 株式会社Adeka Trifunctional compounds and polymer liquid crystals
US6773766B2 (en) 1998-12-22 2004-08-10 Basf Aktiengesellschaft Utilization of polymerizable liquid crystal substances for the production of optical components
DE19859584A1 (en) 1998-12-22 2000-06-29 Basf Ag Use of polymerizable liquid-crystalline substances for the production of optical components
DE19913604A1 (en) 1999-03-25 2000-09-28 Basf Ag Chiral compounds and their use as chiral dopants for the production of cholesteric liquid-crystalline compositions
ATE266075T1 (en) 2000-12-18 2004-05-15 Asulab Sa CHIRAL DOPANTS FOR PRODUCING A VARIABLE HELICAL PITCH AND THEIR APPLICATION IN A MULTI-COLOR REFLECTIVE DISPLAY
JP4058480B2 (en) 2001-03-12 2008-03-12 日東電工株式会社 Liquid crystalline (meth) acrylate compound, liquid crystal composition containing the compound, and optical film using them
JP4058481B2 (en) 2001-04-12 2008-03-12 日東電工株式会社 Polymerizable liquid crystal compound and optical film
TW555837B (en) 2001-07-02 2003-10-01 Merck Patent Gmbh Chiral compounds
EP1432716A1 (en) * 2001-09-24 2004-06-30 Koninklijke Philips Electronics N.V. Isosorbide derivatives
US6848720B2 (en) * 2002-08-09 2005-02-01 The Boeing Company Shrouded fluid-conducting apparatus
JP4721721B2 (en) 2004-02-18 2011-07-13 株式会社Adeka Polymerizable compound and polymerizable liquid crystal composition containing the compound
JP2005309255A (en) 2004-04-23 2005-11-04 Asahi Denka Kogyo Kk Orientating polymer
JP5103774B2 (en) * 2006-03-30 2012-12-19 Dic株式会社 Polymerizable chiral compound
JP2008057896A (en) 2006-08-31 2008-03-13 Nidec Sankyo Corp Manufacturing method of ice making device, and ice making device
JP2008092093A (en) 2006-09-29 2008-04-17 Yamaha Corp Musical sound reproducing apparatus and program
JP4445950B2 (en) 2006-09-29 2010-04-07 日本電信電話株式会社 Service providing system, service providing method, and service providing apparatus
JP4994851B2 (en) 2007-01-15 2012-08-08 京セラドキュメントソリューションズ株式会社 Cleaning device and image forming apparatus equipped with the same
JP5401822B2 (en) 2007-04-24 2014-01-29 日本ゼオン株式会社 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body
JP5401823B2 (en) 2007-12-19 2014-01-29 日本ゼオン株式会社 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body
KR101233950B1 (en) 2007-04-24 2013-02-15 제온 코포레이션 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optically anisotropic material
TW200946649A (en) * 2007-12-19 2009-11-16 Zeon Corp Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical isomer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8287969B2 (en) 2010-10-06 2012-10-16 Industrial Technology Research Institute Isosorbide derivatives and liquid crystal displays comprising the same

Also Published As

Publication number Publication date
TWI450902B (en) 2014-09-01
CN102171216A (en) 2011-08-31
EP2332942A4 (en) 2012-05-23
US8603357B2 (en) 2013-12-10
JP5522047B2 (en) 2014-06-18
KR101298371B1 (en) 2013-08-20
US20110186777A1 (en) 2011-08-04
EP2332942A1 (en) 2011-06-15
WO2010038591A1 (en) 2010-04-08
EP2332942B1 (en) 2013-08-07
KR20110059862A (en) 2011-06-07
JPWO2010038591A1 (en) 2012-03-01
CN102171216B (en) 2014-07-23

Similar Documents

Publication Publication Date Title
TW201014862A (en) Polymerizable chiral compound, polymerizable liquid crystalline composition, liquid crystalline polymer, and optical isomer
JP5401822B2 (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body
JP5510321B2 (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body
KR101233950B1 (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optically anisotropic material
JP2018145192A (en) Polymerizable compound and optically anisotropic material
JP6402976B2 (en) Polymerizable compound and optical anisotropic body
KR20100014882A (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optically anisotropic substance
TW201808878A (en) Compound polymerizable compound mixture polymerizable liquid crystal composition polymer optical film optically anisotropic material polarizing plate flat panel display device organic electroluminescence display device and antireflection film
JP6531935B2 (en) Polymerizable compound and optically anisotropic material
JP2022537630A (en) Novel polymerizable liquid crystal with carbazole core
JP5401823B2 (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body
JP5621584B2 (en) Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystalline polymer and optical anisotropic body
JP5407870B2 (en) Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optical anisotropic body
JP6304529B2 (en) Polymerizable compound and optical anisotropic body
JP6418476B1 (en) Polymerizable compound and optical anisotropic body
TW201124509A (en) Polymerizable compound.
JP5737283B2 (en) Polymerizable chiral compound, polymerizable liquid crystal composition, liquid crystalline polymer and optical anisotropic body
EP3990568A1 (en) New polymerizable liquid crystal having a quinoxaline-hydrazone core
TW200909413A (en) Compound and optical film
JP6772549B2 (en) Polymerizable compounds and optical anisotropics